<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1196016</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Natural products in attenuating renal inflammation <italic>via</italic> inhibiting the NLRP3 inflammasome in diabetic kidney disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2076801"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sui</surname>
<given-names>Zhun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1817506"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Mi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Peng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/506665"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Nephrology, Peking University People&#x2019;s Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Chaofeng Han, Second Military Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Andi Alijagic, &#xd6;rebro University, Sweden; Guangchuan Wang, Jinzhou Medical University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Peng Liu, <email xlink:href="mailto:drliupeng@sina.cn">drliupeng@sina.cn</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1196016</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>03</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Wang, Sui, Wang and Liu</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Wang, Sui, Wang and Liu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Diabetic kidney disease (DKD) is a prevalent and severe complications of diabetes and serves as the primary cause of end-stage kidney disease (ESKD) globally. Increasing evidence indicates that renal inflammation is critical in the pathogenesis of DKD. The nucleotide - binding oligomerization domain (NOD) - like receptor family pyrin domain containing 3 (NLRP3) inflammasome is the most extensively researched inflammasome complex and is considered a crucial regulator in the pathogenesis of DKD. The activation of NLRP3 inflammasome is regulated by various signaling pathways, including NF- &#x3ba;B, thioredoxin&#x2014;interacting protein (TXNIP), and non-coding RNAs (ncRNA), among others. Natural products are chemicals extracted from living organisms in nature, and they typically possess pharmacological and biological activities. They are invaluable sources for drug design and development. Research has demonstrated that many natural products can alleviate DKD by targeting the NLRP3 inflammasome. In this review, we highlight the role of the NLRP3 inflammasome in DKD, and the pathways by which natural products fight against DKD <italic>via</italic> inhibiting the NLRP3 inflammasome activation, so as to provide novel insights for the treatment of DKD.</p>
</abstract>
<kwd-group>
<kwd>natural products (NP)</kwd>
<kwd>diabetic kidney disease (DKD)</kwd>
<kwd>inflammation</kwd>
<kwd>the NLRP3 inflammasome</kwd>
<kwd>NF- &#x3ba;B</kwd>
<kwd>TXNIP (thioredoxin interacting protein)</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="280"/>
<page-count count="20"/>
<word-count count="8047"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Innate Immunity</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Diabetic kidney disease (DKD) is one of the most prevalent and severe microvascular complications of diabetes, and is also the main cause of end stage kidney disease (ESKD) globally. Approximately 30% to 50% of ESKD cases worldwide are attributed to DKD (<xref ref-type="bibr" rid="B1">1</xref>). The pathogenesis of DKD is multifaceted, involving metabolic abnormalities, renal hemodynamics changes, oxidative stress, and inflammation, among others.</p>
<p>Initially, metabolic and hemodynamic changes were believed to be the main factors in the development of DKD. However, it is gradually realized that inflammation plays an important role in the development and progression of DKD (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Chronic exposure to advanced glycation end products (AGEs) stimulates the release of chemokines and cytokines, which can be recognized by Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors (NLRs), leading to heightened inflammatory responses. Persistent inflammation ultimately results in the onset of DKD (<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>Natural products include a diverse group of substances extracted from various natural sources such as plants, bacteria, fungi, insects, and even animals, they are valuable sources for drug design and development (<xref ref-type="bibr" rid="B5">5</xref>). Accumulative evidence demonstrates that many natural products could suppress systemic and renal inflammation by targeting nuclear transcription factor-&#x3ba;B (NF-&#x3ba;B), NLR family pyrin domain containing 3 (NLRP3) inflammasome, transforming growth factor-&#x3b2; (TGF-&#x3b2;) signaling pathway, and exhibit reno-protective effects on DKD (<xref ref-type="bibr" rid="B6">6</xref>). The NLRP3 inflammasome is a critical regulator of inflammation in DKD and is considered a potential therapeutic target (<xref ref-type="bibr" rid="B7">7</xref>). In this review, we highlight the role of NLRP3 inflammasome in DKD, and the pathways by which natural products fight against DKD <italic>via</italic> inhibiting the NLRP3 inflammasome activation, so as to offer novel insights for the treatment of DKD.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>A brief overview of the NLRP3 inflammasome in DKD</title>
<p>As a member of NLR, NLRP3 can assemble into the NLRP3 inflammasome after recognizing danger signals, and exert biological effects by activating caspase-1 and promoting the maturation and secretion of interleukin (IL)-1&#x3b2; and IL-18. The NLRP3 inflammasome is a multiprotein complex composed of NLRP3, apoptosis-associated speck-like protein (ASC), and caspase-1. Among them, NLRP3 is the core protein, containing three different domains. First is the pyrin domain (PYD) or C-terminal caspase-recruitment domain (CARD), located on the N-terminus. It can bind to other proteins, and mediate signal transduction. Second is the NACHT domain located in the middle, responsible for activating the NLRP3 inflammasome through ATP-dependent oligomerization. Third is the leucine-rich repeat (LRR) domain, which located on the C-terminus, and is responsible for identifying pathogenic organisms and endogenous danger signals. ASC is an adaptor protein that connects upstream NLRP3 to downstream caspase-1. Caspase-1 is the effector protein in NLRP3 inflammasome, it induces the production and IL-1&#x3b2; and IL-18, resulting in inflammation (<xref ref-type="bibr" rid="B8">8</xref>).</p>
</sec>
<sec id="s3">
<label>3</label>
<title>The NLRP3 inflammasome regulator in DKD</title>
<p>NLRP3 is widely expressed in glomerular and tubular epithelial cells of DKD patients and mice. Inhibition of NLRP3, ASC, or caspase-1 can reduce the damage of podocytes, endothelial cells and mesangial cells, and can also significantly reduce the inflammatory response of tubulointerstitium. NLRP3 knockout improved renal pathological changes in diabetic mice (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). These findings suggest that the NLRP3 inflammasome plays a significant role in DKD.</p>
<p>The activation of the NLRP3 inflammasome is a two-step process. The &#x201c;priming step&#x201d; is the first phase, involving recognition of danger signals by TLR and activation of NF-&#x3ba;B, which will up-regulate the expression of NLRP3, pro-IL-1&#x3b2; and pro-IL-18. The &#x201c;activating step&#x201d; is the second phase, triggered by potassium efflux, calcium influx, mitochondrial dysfunction, lysosomal disruption and reactive oxygen species (ROS) overproduction. These danger signals promote the formation of the NLRP3 inflammasome (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>). It is found that multiple signaling pathways can exacerbate DKD by targeting the NLRP3 inflammasome activation (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Signaling pathways regulating the NLRP3 inflammasome activation in DKD.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Signaling Pathways</th>
<th valign="middle" align="left">
<italic>In vivo/in vitro</italic>
</th>
<th valign="middle" align="left">Model</th>
<th valign="middle" align="left">Findings</th>
<th valign="middle" align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="4" align="left">NF-&#x3ba;B</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse podocytes</td>
<td valign="middle" align="left">TLR4 knockdown inhibited NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B14">14</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice<break/>mouse mesangial cell</td>
<td valign="middle" align="left">TLR9 knockdown inhibited NF-&#x3ba;B and NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B15">15</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD Patients<break/>HFD/STZ mice<break/>MPC5</td>
<td valign="middle" align="left">FOXM1 activated SIRT4, inhibited NF-&#x3ba;B and NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B16">16</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice<break/>STZmice<break/>DKD Patients<break/>HK-2 cells</td>
<td valign="middle" align="left">CXCL1/CXCR2 activated NF-&#x3ba;B and the NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B17">17</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="16" align="left">TXNIP</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>HK-2 cells</td>
<td valign="middle" align="left">TXNIP promoted NLRP3 inflammasome activation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B18">18</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD Patients<break/>STZ mice<break/>human podocyte cell line</td>
<td valign="middle" align="left">TXNIP activated NADPH oxidase and then triggered NLRP3 inflammasome activation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B19">19</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>Rat glomerular mesangial cells</td>
<td valign="middle" align="left">ROS inhibitor down-regulated TXNIP, NLRP3 and IL-1&#x3b2;</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B20">20</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">db/db mice<break/>HK-2 cells</td>
<td valign="middle" align="left">mtROS upregulated TXNIP, NLRP3 and IL-1&#x3b2;</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B21">21</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">HFD/STZ Rats</td>
<td valign="middle" align="left">IRE1stimulated TXINP and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B22">22</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Human podocyte cell line</td>
<td valign="middle" align="left">EZH2/EGR1/TXNIP/NLRP3 pathway contributed to DKD</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B23">23</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice<break/>NRK52E cell line</td>
<td valign="middle" align="left">Sphingosine kinase 2 activated TXINP, NLRP3, and IL-1&#x3b2;</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B24">24</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Human glomerular podocytes</td>
<td valign="middle" align="left">NOX4 upregulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B25">25</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>Mouse podocytes</td>
<td valign="middle" align="left">Icariin inhibited NLRP3 by Keap1-Nrf2/HO-1 pathway</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B26">26</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">Db/db mice</td>
<td valign="middle" align="left">Minocycline stabilized Nrf2 and inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B27">27</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ mice</td>
<td valign="middle" align="left">Berberine stabilized Nrf2 and inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B28">28</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">Zinc Oxide Regulated Nrf2/TXNIP/NLRP3 Inflammasome pathway</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B29">29</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">db/db mice<break/>HK-2 cells</td>
<td valign="middle" align="left">CD36 promoted mtROS and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B30">30</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Mouse proximal tubular cells</td>
<td valign="middle" align="left">Activated Protein C inhibited ROS and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B31">31</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse glomerular mesangial cells</td>
<td valign="middle" align="left">RIPK2 inhibited ROS and NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B32">32</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>Murine renal tubular epithelial cells</td>
<td valign="middle" align="left">Optineurin reduced mtROS and inhibited NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B33">33</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="15" align="left">Non-coding RNAs</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>STZ mice&amp; db/db mice<break/>Human podocytes</td>
<td valign="middle" align="left">MiRNA-10 negatively regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B34">34</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse glomerular podocyte line</td>
<td valign="middle" align="left">MiRNA-29a inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B35">35</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD Patients<break/>HK-2 cells</td>
<td valign="middle" align="left">MiR-520c-3p inhibited TXNIP/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B36">36</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>HK-2 cells</td>
<td valign="middle" align="left">IncRNA-MALAT1 down-regulated miR-23c and up-regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B37">37</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">MPC-5 cells</td>
<td valign="middle" align="left">Atorvastatin protected podocytes by regulating MALAT1/miR-200c/Nrf2</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B38">38</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>Vitro</italic>
</td>
<td valign="middle" align="left">HK-2 cells</td>
<td valign="middle" align="left">IncRNA-MALAT1 down-regulated miR-30c and up-regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B39">39</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>HBZY-1 cells</td>
<td valign="middle" align="left">IncRNA-NEAT1 down-regulated miR-34c and up-regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B40">40</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">HK-2 cells</td>
<td valign="middle" align="left">IncRNA-NEAT2 down-regulated miR-206 and up-regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B41">41</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>HK-2 cells</td>
<td valign="middle" align="left">IncRNA-XIST down-regulated miRNA-15b-5p, upregulated TLR4 and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>HK-2 cells</td>
<td valign="middle" align="left">IncRNA-KCNQ1OT1 down-regulated miRNA-506-3p and up-regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B43">43</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">HK-2 cells</td>
<td valign="middle" align="left">lncRNA-GAS5 down-regulated miR-452-5p and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B44">44</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse podocyte cell line</td>
<td valign="middle" align="left">sC5b-9 promoted NLRP3 activation <italic>via</italic> up-regulating Kcnq1to1and down-regulating mRNA-486a-3p</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B45">45</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>HK-2 cells</td>
<td valign="middle" align="left">lncRNA-ANRIL down-regulated miRNA-497, and up-regulated TXNIP/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B46">46</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse mesangial cells</td>
<td valign="middle" align="left">IncRNA-Gm4419 knockdown inhibited NF-&#x3ba;B and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B47">47</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>HK-2 cells</td>
<td valign="middle" align="left">Circ_0004951 down-regulated miRNA-93-5p, and up-regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B48">48</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="3" align="left">Interleukin</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">Db/db mice</td>
<td valign="middle" align="left">Blockade of IL-6 receptor inhibited NLRP3 by regulating IL-17A</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B49">49</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>STZ mice<break/>HEK293T cells</td>
<td valign="middle" align="left">IL-22 inhibited NLRP3/caspase-1/IL-1&#x3b2;</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B50">50</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse Podocyte</td>
<td valign="middle" align="left">IL-37 inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B51">51</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">BTK</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>STZ mice</td>
<td valign="middle" align="left">BTK activated NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B52">52</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">HFD mice<break/>Murine bone marrow-derived macrophages<break/>Human monocyte-derived macrophages</td>
<td valign="middle" align="left">BTK inhibitor suppressed NLRP3 <italic>via</italic> regulating IRS-1/Akt/GSK-3&#x3b2;</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B53">53</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">GSK-3&#x3b2;/HIF-1&#x3b1;</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse renal proximal tubular epithelial cells</td>
<td valign="middle" align="left">GSK-3&#x3b2; knockdown decreased NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B54">54</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">HDAC6</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>STZ mice<break/>Mouse Bone Marrow&#x2013;Derived Macrophages<break/>HK-2 cells</td>
<td valign="middle" align="left">HDAC6 inhibitor suppressed NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B55">55</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">RIPK3</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ mice</td>
<td valign="middle" align="left">RIPK3 controls cellular signaling through the formation of NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B56">56</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Syk/JNK</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>HK-2 cells<break/>Rat glomerular mesangial cells</td>
<td valign="middle" align="left">Syk/JNK activated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B57">57</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">PPARs</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">Sugar-induced mice with diabesity</td>
<td valign="middle" align="left">PPAR-&#x3b4; agonists inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B58">58</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">RAC1</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice<break/>HEK293T cells</td>
<td valign="middle" align="left">RAC1 binding to NLRP3 activates the NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B59">59</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Spop</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Mice podocytes</td>
<td valign="middle" align="left">Spop promoted NLRP3 degradation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B60">60</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">WTAP</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">DKD patients<break/>HK-2 cells</td>
<td valign="middle" align="left">WTAP upregulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B61">61</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>CXCL1, Chemokine (C-X-C motif) Ligand 1 Protein; CXCR2, CXC chemokine receptor 2; EGR1, Early Growth Response Protein 1; EZH2, Enhancer of zeste homolog 2; FOXM1, Forkhead box M1; GSK-3&#x3b2;, Glycogen synthase kinase-3&#x3b2;; HDAC6, Histone deacetylase 6; HFD, High-Fat Diet; HIF, Hypoxia inducible factor; IRE1, Inositol-requiring enzyme 1; JNK, c-Jun N-terminal kinase; MPC, mouse podocyte cell; NLRP3, The nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3; NOX4, Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4; PPARs, Peroxisome-proliferator activated receptors; RAC1,Ras-related C3 botulinum toxin substrate 1; RIPK, Receptor interacting protein kinase; ROS, reactive oxygen species; SIRT4, sirtuin 4; STZ, Streptozocin; Spop, Speckle-type POZ protein; Syk, Spleen tyrosine kinase; TLR, Toll-like receptors; TXNIP, thioredoxin-interacting protein; WTAP, Wilms tumor 1-associated protein.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="s3_1">
<label>3.1</label>
<title>NF-&#x3ba;B/NLRP3 signaling pathway</title>
<p>NF-&#x3ba;B is a transcription factor in the form of p50/p65 heterodimer. Normally, NF-&#x3ba;B binds to its inhibitor kappa B (I&#x3ba;B) and becomes inactive. When stimulus signals activate I&#x3ba;B kinase, I&#x3ba;B-&#x3b1; is phosphorylated and degraded, allowing NF-&#x3ba;B and I&#x3ba;B are dissociated and translocated into nucleus, where they regulate the expression of target genes (<xref ref-type="bibr" rid="B62">62</xref>). Liu et&#xa0;al. (<xref ref-type="bibr" rid="B14">14</xref>) revealed that high glucose (HG) promoted the activation of NLRP3 inflammasome in mouse podocytes (MPCs). The expression of TLR4 was also upregulated, which is an important signaling molecule regulating NF-&#x3ba;B. TLR4 knockdown inhibited the activation of NLRP3 inflammasome, attenuated HG-induced cell apoptosis, and increased cell viability. Shen et&#xa0;al (<xref ref-type="bibr" rid="B15">15</xref>) found that TLR9 knockdown would inhibit NF-&#x3ba;B/NLRP3 pathway in HG-induced Mesangial Cells (MCs). Furthermore, inhibition of TLR9 reduced NF-&#x3ba;B and NLRP3 expression, and decreased microalbuminuria, renal inflammatory response, and glomerular lesion in db/db mice. Xu et&#xa0;al (<xref ref-type="bibr" rid="B16">16</xref>) demonstrated that Forkhead box M1(FOXM1) transcriptionally activated sirtuin 4 (SIRT4) and inhibited NF-&#x3ba;B signaling and the NLRP3 inflammasome, thereby alleviating renal injury <italic>in vivo</italic> and <italic>in vitro</italic>. Tang et&#xa0;al. (<xref ref-type="bibr" rid="B17">17</xref>) also confirmed that CXCL1/CXCR2 may cause inflammation in HK-2 cells with HG treatment by phosphorylating NF-&#x3ba;B and activating the NLRP3 inflammasome. Li et&#xa0;al. (<xref ref-type="bibr" rid="B63">63</xref>) found that the activation of AMPK/SIRT1 pathway promoted the expression of NF-&#x3ba;B, NLRP3, ASC, Caspase-1, and IL-1&#x3b2; in DKD mice.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>TXNIP/NLRP3 signaling pathway</title>
<p>Thioredoxin-interacting protein (TXNIP) is an alpha-arrestin protein with a molecular weight of 46 kD. It can bind to thioredoxin (TRX) and interfere with its expression, which is an essential regulator of oxidative stress, cell proliferation, and apoptosis (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>). It has been revealed that TXNIP is released from oxidized TRX under oxidative stress, resulting in the activation of NLRP3 inflammasome (<xref ref-type="bibr" rid="B66">66</xref>).</p>
<p>There is abundant evidence that TXNIP/NLRP3 signaling pathway is involved in the inflammatory response of DKD. For instance, Gu et&#xa0;al. (<xref ref-type="bibr" rid="B18">18</xref>) revealed that TXNIP and NLRP3 were overexpressed in the renal tissue of DKD rats. It is also observed that HG stimulated TXNIP/NLRP3, promoting inflammation. Gao et&#xa0;al. (<xref ref-type="bibr" rid="B19">19</xref>) found that HG-promoted Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase activation <italic>via</italic> TXNIP, which in turn activated the NLRP3 inflammasome, leading to podocyte injury. It has also been revealed that HG activates ROS/TXNIP/NLRP3 inflammasome signaling in glomerular mesangial cells (<xref ref-type="bibr" rid="B20">20</xref>), and mitochondrial ROS(mt ROS)/TXNIP/NLRP3 pathway is involved in tubular oxidative injury in DKD (<xref ref-type="bibr" rid="B21">21</xref>). Furthermore, it has been confirmed that many molecules participate in the pathogenesis of DKD by regulating TXNIP/NLRP3 inflammasome pathway. Inositol-requiring enzyme 1&#x3b1; (IRE1&#x3b1;), an endoplasmic reticulum transmembrane sensor, can stimulate TXINP/NLRP3 signaling pathway and aggravate DKD in rat model (<xref ref-type="bibr" rid="B22">22</xref>). Enhancer of zeste homolog 2 (EZH2), a subunit of the polycomb repressive complex 2, contributes to S-adenosylhomocysteine inhibition-aggravated DKD in mice through EZH2/EGR1/TXNIP/NLRP3 signaling pathway (<xref ref-type="bibr" rid="B23">23</xref>). Sphingosine kinase 2 (SphK2) is a key enzyme catalyzing the formation of sphingosine-1-phosphate. Research shows that SphK2 increases TXNIP, NLRP3 inflammasome and IL-1&#x3b2; levels, induces inflammation, promotes renal tubular epithelial cell damage, leading to DKD aggravation (<xref ref-type="bibr" rid="B24">24</xref>).</p>
<p>Additionally, there is substantial evidence that many molecules contribute to DKD progression through the ROS/NLRP3 inflammasome pathway. It is found that NADPH oxidase 4 (NOX4), a major source of ROS, is upregulated in HG-induced podocytes. Suppression of NOX4 inhibits the activation of NLRP3 inflammasome and alleviates podocytes apoptosis (<xref ref-type="bibr" rid="B25">25</xref>). Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that protects cells from oxidative stress (<xref ref-type="bibr" rid="B67">67</xref>) and serves as most sensitive signal of scavenging ROS under oxidative stress (<xref ref-type="bibr" rid="B68">68</xref>). It is reported that Nrf2 may alleviate DKD by suppressing the activation of NLRP3 inflammasome (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B29">29</xref>). CD36, a fatty acid transporter, causes renal tubular epithelial cell injury by activating mtROS/NLRP3 pathway in DKD (<xref ref-type="bibr" rid="B30">30</xref>). Activated protein C (aPC), an endothelial-dependent cytoprotective coagulation protease, meliorates tubular mitochondrial ROS and inflammation in DKD (<xref ref-type="bibr" rid="B31">31</xref>). Receptor interacting protein kinase 2 (RIPK2) has also been confirmed to negatively regulate ROS/NLRP3 signaling in mouse glomerular mesangial cells treated with HG (<xref ref-type="bibr" rid="B32">32</xref>). Optineurin, a well-recognized autophagy receptor, reduces the activation of NLRP3 inflammasome by reducing mtROS and mitophagy in HG -treated renal tubular cells (<xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Non-coding RNAs</title>
<p>Non-coding RNAs (ncRNAs) are recognized as a class of ribonucleic acids (RNAs) that are not translated into proteins. ncRNAs consist of various family members, including microRNAs (miRNAs), long ncRNAs (lncRNAs), ribosomal RNAs, transfer RNAs, circular RNAs(circ-RNAs), and others. Different classes of ncRNAs engage in different cellular processes, regulating gene expression, RNA maturation, and protein synthesis (<xref ref-type="bibr" rid="B69">69</xref>).</p>
<p>MiRNAs are small ncRNAs that regulate gene expression through recognizing cognate sequences and interfering with transcriptional, translational, and epigenetic processes. Many miRNAs have been shown to participate in the pathogenesis of DKD by regulating the NLRP3 inflammasome. For example, Ding et&#xa0;al (<xref ref-type="bibr" rid="B34">34</xref>) found that miRNA-10 alleviated inflammation in DKD by reducing the NLRP3 inflammasome activation. Zhang (<xref ref-type="bibr" rid="B35">35</xref>) demonstrated that miRNA-29a inhibited HG-induced podocytes pyroptosis and alleviated inflammatory response by directly targeting NLRP3. Song et&#xa0;al (<xref ref-type="bibr" rid="B36">36</xref>) revealed that miR&#x2212;520c&#x2212;3p reduced HK-2 cell pyroptosis induced by HG through inhibiting TXNIP/NLRP3 inflammasome pathway.</p>
<p>LncRNAs are defined as ncRNAs containing more than 200 nucleotides in length (<xref ref-type="bibr" rid="B70">70</xref>). They act through numerous paradigms and are key regulatory molecules in cells (<xref ref-type="bibr" rid="B71">71</xref>). It is found that in diabetic rats and HG treated podocytes/renal tubule (HK-2) cells, the up-regulation of lncRNA-MALAT1 promoted the NLRP3 inflammasome activation <italic>via</italic> inhibiting miR-23c (<xref ref-type="bibr" rid="B37">37</xref>), miR-200c (<xref ref-type="bibr" rid="B38">38</xref>) and miR-30c (<xref ref-type="bibr" rid="B39">39</xref>). In addition, many other lncRNAs have also been confirmed to take part in the development of DKD by targeting NLRP3 inflammasome, such as IncRNA-NEAT1/miR-34c (<xref ref-type="bibr" rid="B40">40</xref>), lncRNA NEAT2/miR-206 (<xref ref-type="bibr" rid="B41">41</xref>), lncRNA-XIST/miR-15b-5p (<xref ref-type="bibr" rid="B42">42</xref>), lncRNA-KCNQ1OT1/miR-506-3p (<xref ref-type="bibr" rid="B43">43</xref>), lncRNA-GAS5/miR-452-5p (<xref ref-type="bibr" rid="B44">44</xref>), Kcnq1ot1/miR-486a-3p (<xref ref-type="bibr" rid="B45">45</xref>), lncRNA-ANRIL/miR-497 (<xref ref-type="bibr" rid="B46">46</xref>), and lncRNA-Gm4419 (<xref ref-type="bibr" rid="B47">47</xref>).</p>
<p>Circular RNAs(circ-RNAs) are a class of ncRNAs that lack the 5&#x2019; or 3&#x2019; end. They regulate gene expression by pervading the transcription, the mRNA turnover, and translation. It is showed that Circ_0004951 is significantly up-regulated in DKD, where it can suppress miR-93-5p and activate NLRP3 inflammasome (<xref ref-type="bibr" rid="B48">48</xref>).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Others</title>
<p>Interleukin (IL): ILs are a type of cytokine released by various cells, playing a crucial role in immune regulation and homeostasis. Many ILs have been confirmed to be involved in renal damage caused by diabetes through the regulation of the NLRP3 inflammasome. Wu et&#xa0;al. (<xref ref-type="bibr" rid="B49">49</xref>) found that blocking the IL-6 receptor inhibited the NLRP3 inflammasome by restraining IL-17A. Wang et&#xa0;al. (<xref ref-type="bibr" rid="B50">50</xref>) demonstrated that IL-22 has reno-protective effects on DKD by downregulating renal NLRP3/caspase-1/IL-1&#x3b2; pathway. Zhang et&#xa0;al. (<xref ref-type="bibr" rid="B51">51</xref>) found that IL-37 decreased the expression of NLRP3, ASC, and caspase-1 in HG-treated podocytes.</p>
<p>Bruton&#x2019;s tyrosine kinase (BTK): BTK, an intracellular non-receptor tyrosine kinase, is considered as an vital signal in immunoregulation (<xref ref-type="bibr" rid="B72">72</xref>). It has been observed that BTK activates the NLRP3 inflammasome and promotes renal inflammation in diabetic patients and mice (<xref ref-type="bibr" rid="B52">52</xref>). BTK inhibitor attenuates NLRP3 inflammasome activation and alleviates DKD (<xref ref-type="bibr" rid="B53">53</xref>).</p>
<p>Glycogen synthase kinase (GSK)-3&#x3b2;/Hypoxia inducible factor(HIF)-&#x3b1;: GSK-3&#x3b2;, a serine/threonine kinase, is crucial for glycogen synthesis by regulating phosphorylation of glycogen synthase (<xref ref-type="bibr" rid="B73">73</xref>). It is found that HIF-1&#x3b1; is also a direct target of GSK-3&#x3b2; (<xref ref-type="bibr" rid="B74">74</xref>). Inhibition of the GSK-3&#x3b2;/HIF-1&#x3b1; pathway has been shown to alleviate NLRP3-induced pyroptosis in HG-treated renal tubular epithelial cells (<xref ref-type="bibr" rid="B54">54</xref>).</p>
<p>Histone deacetylase 6 (HDAC6):HDAC6 is a cytoplasmic enzyme that participates in a variety of cellular processes (<xref ref-type="bibr" rid="B75">75</xref>). Inhibition of HDAC6 has been shown to ameliorate DKD by suppressing the NLRP3 inflammasome (<xref ref-type="bibr" rid="B55">55</xref>).</p>
<p>Receptor-interacting protein kinase-3 (RIPK3): RIPK3 is a multifunctional regulator of cell death and inflammation. It is reported that RIPK3 is associated with renal fibrosis in DKD by activating NLRP3 inflammasome. Blockade of RIPK3 attenuates tubulointerstitial fibrosis (<xref ref-type="bibr" rid="B56">56</xref>).</p>
<p>Spleen tyrosine kinase (Syk)/c-Jun N-terminal kinase (JNK)/NLRP3 signaling pathway: Syk is a non-receptor protein tyrosine kinase. Inhibition of Syk has been shown to downregulate JNK expression and suppress the activation of the NLRP3 inflammasome stimulated by HG, indicating that the Syk/JNK/NLRP3 pathway may play a role in the inflammatory injury in DKD (<xref ref-type="bibr" rid="B57">57</xref>).</p>
<p>Peroxisome-proliferator activated receptors (PPARs): PPARs belong to the nuclear receptor superfamily, with three subtypes: PPAR-&#x3b1;, PPAR-&#x3b3;, and PPAR&#x3b2;/&#x3b4;. They regulate glucose and lipid metabolism and also mediate inflammation (<xref ref-type="bibr" rid="B76">76</xref>). It is reported that PPAR-&#x3b4; agonist attenuates renal dysfunction and inflammation by preventing activation of the NLRP3 inflammasome in diabesity mice (<xref ref-type="bibr" rid="B58">58</xref>).</p>
<p>Ras-related C3 botulinum toxin substrate 1 (RAC1): RAC1 is a member of the Rho family of small GTPases and plays a role in cell proliferation, apoptosis, and inflammation (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>). It is revealed that RAC1 binding to NLRP3 activates the NLRP3 inflammasome in the kidney and accelerates DKD pathological processes (<xref ref-type="bibr" rid="B59">59</xref>).</p>
<p>Speckle-type POZ protein (Spop): Spop, an E3 ubiquitin ligase, is involved in many cellular processes by promoting the degradation of its target proteins (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B80">80</xref>). It is observed that Spop inhibits the NLRP3 inflammasome and ameliorates DKD, the possible mechanism is that Spop may directly contact with NLRP3 and promote NLRP3 degradation <italic>via</italic> elevating K48-linked polyubiquitination of NLRP3 (<xref ref-type="bibr" rid="B60">60</xref>).</p>
<p>Wilms tumor 1-associated protein (WTAP): WTAP is a critical constituent of the classical m6A methyltransferase, which may cause modification of NLRP3. It has been demonstrated that WTAP upregulates the expression of NLRP3 by increasing the m6A methylation of NLRP3 mRNA, leading to inflammatory response (<xref ref-type="bibr" rid="B61">61</xref>).</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Natural products alleviating DKD <italic>via</italic> targeting the NLRP3 inflammasome</title>
<p>Natural products are chemicals extracted from living organisms, and usually have pharmacological or biological activities. They are highly beneficial for drug design and development. Numerous natural products have been found to alleviate DKD by targeting the NLRP3 inflammasome (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref> and <xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1</bold>
</xref>, <xref ref-type="fig" rid="f2">
<bold>2</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Natural products in alleviating DKD by targeting the NLRP3 inflammasome.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left"/>
<th valign="middle" align="left">Compounds</th>
<th valign="middle" align="left">Resource</th>
<th valign="middle" align="left">
<italic>In Vivo/in Vitro</italic>
</th>
<th valign="middle" align="left">Model</th>
<th valign="middle" align="left">Signaling Pathways</th>
<th valign="middle" align="left">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="13" align="left">Flavonoids</td>
<td valign="middle" align="left">Naringin</td>
<td valign="middle" align="left">Grapefruit and citrus fruit</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Glomerular mesangial cells</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B81">81</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Quercetin</td>
<td valign="middle" align="left">Apples, grapes, tomatoes, and onions</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B82">82</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Dihydroquercetin</td>
<td valign="middle" align="left">Larix sibirica Ledeb. and Pseudotsuga taxifolia (Lamb.) Britton</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">HFD/STZ rats<break/>HBZY-1 and HK2 cell cells</td>
<td valign="middle" align="left">InhibitedROS and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B83">83</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Fisetin</td>
<td valign="middle" align="left">Vegetables and fruits, apples, persimmons, grapes, strawberries, cucumbers, and onions.</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Mouse podocytes</td>
<td valign="middle" align="left">Inhibited NLRP3 inflammasome</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B84">84</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Fisetin</td>
<td valign="middle" align="left">As above</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">HFD mice<break/>HK-2 cells</td>
<td valign="middle" align="left">InhibitedRIP3/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B85">85</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Liquiritigenin</td>
<td valign="middle" align="left">Glycyrrhizae radix</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">HBZY-1</td>
<td valign="middle" align="left">Decreased NOX4, NF-&#x3ba;B and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B86">86</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Isoliquiritigenin</td>
<td valign="middle" align="left">As above</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">Up-regulated Sirt-1 and inhibited NF-&#x3ba;B/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B87">87</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Icariin</td>
<td valign="middle" align="left">Herba epimedii</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>MPC-5</td>
<td valign="middle" align="left">Inhibited NLRP3 <italic>via</italic> Keap1-Nrf2/HO-1 axis</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B26">26</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Calycosin</td>
<td valign="middle" align="left">Radix Astragali</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">InhibitedNF-&#x3ba;B/p65/NLRP3/TXNIP</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B88">88</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Luteolin</td>
<td valign="middle" align="left">Fruits and vegetables</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">MPC-5</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B89">89</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Complanatoside A</td>
<td valign="middle" align="left">Semen Astragali Complanati</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>HK-2 cells</td>
<td valign="middle" align="left">InhibitedNOX4 and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B90">90</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Kaempferol</td>
<td valign="middle" align="left">Sand ginger</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B91">91</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Carithamine</td>
<td valign="middle" align="left">Safflower</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">Down-regulated NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B92">92</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="9" align="left">Saponins</td>
<td valign="middle" align="left">Ginsenoside Rg1</td>
<td valign="middle" align="left">Ginseng</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>Mouse podocyte cell line BNCC337685</td>
<td valign="middle" align="left">Inhibited mTOR/NF-&#x3ba;B/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B93">93</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Ginsenoside Rg5</td>
<td valign="middle" align="left">Black ginseng</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ mice</td>
<td valign="middle" align="left">InhibitedROS, Nox4, TXNIP, NF-&#x3ba;B, MAPK, and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B94">94</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Ginsenoside compound K</td>
<td valign="middle" align="left">Diol-type ginsenosides</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>HBZY-1</td>
<td valign="middle" align="left">InhibitedROS/NLRP3 and NF-&#x3ba;B/p38</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B95">95</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Sarsasapogenin</td>
<td valign="middle" align="left">Anemarrhena asphodeloides Bunge</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>Human mesangial cells</td>
<td valign="middle" align="left">Suppressed NLRP3 and NF-&#x3ba;B by down-regulating PAR-1</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B96">96</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Sarsasapogenin</td>
<td valign="middle" align="left">As above</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B97">97</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Astragaloside IV</td>
<td valign="middle" align="left">Astragalus membranaceus</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice<break/>Mouse podocytes</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B98">98</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Astragaloside IV</td>
<td valign="middle" align="left">As above</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse mesangial cells(SV40)</td>
<td valign="middle" align="left">Inhibited ROS and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B99">99</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Salidroside</td>
<td valign="middle" align="left">Rhodiola rosea</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">HBZY-1</td>
<td valign="middle" align="left">InhibitedTXNIP-NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B100">100</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Notoginsenoside Fc</td>
<td valign="middle" align="left">Panax notoginseng</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">Db/db mice</td>
<td valign="middle" align="left">Inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B101">101</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="9" align="left">Phenolics</td>
<td valign="middle" align="left">Tetrahydroxy stilbene glucoside</td>
<td valign="middle" align="left">Polygoni Multiflori Radix</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">MPC5</td>
<td valign="middle" align="left">Inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B102">102</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Gastrodin</td>
<td valign="middle" align="left">Gastrodia elata</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">MPC-5 cells</td>
<td valign="middle" align="left">Actived AMPK/Nrf2 and inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B103">103</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Epigallocatechin-3-gallate</td>
<td valign="middle" align="left">Green tea</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">HFD/STZ rats</td>
<td valign="middle" align="left">suppressed endoplasmic reticulum stress-mediated NLRP3 inflammasome overactivation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B104">104</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Resveratrol</td>
<td valign="middle" align="left">Grape skin and red wine</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats HK-2 cells</td>
<td valign="middle" align="left">Inhibited TXNIP binding to NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B105">105</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Piceatannol</td>
<td valign="middle" align="left">Grapes, sugar cane, white tea, rhubarb, passion fruit and blueberries</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse podocytes</td>
<td valign="middle" align="left">Upregulated Nrf2 and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B106">106</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Curcumin</td>
<td valign="middle" align="left">Rhizome Curcuma longa- turmeric</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice<break/>HK-2 cells</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B107">107</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Punicalagin</td>
<td valign="middle" align="left">Pomegranate, myrobalan, leaves of yellow wood, and tropical almond</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">HFD/STZ mice</td>
<td valign="middle" align="left">Downregulated NOX4, TXNIP, and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B108">108</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Purple Sweet Potato Color</td>
<td valign="middle" align="left">Ipomoea batatas</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">HFD mice</td>
<td valign="middle" align="left">Suppressed VEGFR2/ROS/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B109">109</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Grape seed proanthocyanidin</td>
<td valign="middle" align="left">Grape seeds</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B110">110</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="8" align="left">Terpenoids</td>
<td valign="middle" align="left">Pristimerin</td>
<td valign="middle" align="left">Celastraceae and Hippocrateaceae</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">HFD Mice<break/>Mouse Bone-marrow cells</td>
<td valign="middle" align="left">Disturbed the interaction between NEK7 and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B111">111</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Geniposide</td>
<td valign="middle" align="left">Gardenia jasminoides Ellis</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Mouse podocytes</td>
<td valign="middle" align="left">InhibitedAMPK/SIRT1/NF-&#x3ba;B, and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B112">112</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Genipin-1-&#x3b2;-d-gentiobioside</td>
<td valign="middle" align="left">As above</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Mouse Podocytes</td>
<td valign="middle" align="left">Inhibited AMPK/SIRT1/NF-&#x3ba;B, and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B63">63</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Swietenine</td>
<td valign="middle" align="left">Swietenia macrophylla King</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice Human mesangial cells</td>
<td valign="middle" align="left">InhibitedNF-&#x3ba;B/NLRP3/Caspase-1</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B113">113</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Artesunate</td>
<td valign="middle" align="left">Artemisia annua</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">HBZY-1</td>
<td valign="middle" align="left">InhibitedTLR4/NF-&#x3ba;B/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B114">114</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Catalpol</td>
<td valign="middle" align="left">Rehmannia glutinosa</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Mouse podocytes</td>
<td valign="middle" align="left">InhibitedAMPK/SIRT1/NF-&#x3ba;B and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B115">115</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Andrographolide</td>
<td valign="middle" align="left">Andrographis paniculata</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>HK-2 cells</td>
<td valign="middle" align="left">Inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B116">116</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Triptolide</td>
<td valign="middle" align="left">Tripterygium wilfordii Hook F</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">Mouse podocytes</td>
<td valign="middle" align="left">Inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B117">117</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="5" align="left">Alkaloids</td>
<td valign="middle" align="left">Berberine</td>
<td valign="middle" align="left">Coptis and Phellodendron</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">HFD/STZ hamsters</td>
<td valign="middle" align="left">Regulated Nrf2/NLRP3 pathway</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B28">28</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Berberine</td>
<td valign="middle" align="left">As above</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ rats<break/>HK-2 cells</td>
<td valign="middle" align="left">InhibitedNLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B118">118</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Piperine and Cepharanthine</td>
<td valign="middle" align="left">Black pepper and Stephania cepharantha Hayata</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ Rats</td>
<td valign="middle" align="left">Both decreased p38MAPK, p-JNK, TNF-&#x3b1;, TXNIP,NF-&#x3ba;B and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B119">119</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Solasonine</td>
<td valign="middle" align="left">Solanummelongena</td>
<td valign="middle" align="left">
<italic>In vitro</italic>
</td>
<td valign="middle" align="left">MPC-5</td>
<td valign="middle" align="left">Regulated Nrf2/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B120">120</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Rutaecarpine</td>
<td valign="middle" align="left">Euodia rutaecarpine</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">Db/db mice<break/>MPC-5</td>
<td valign="middle" align="left">Down-regulatedVEGFR2/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B121">121</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="3" align="left">Phenylpropanoids</td>
<td valign="middle" align="left">Schisandrin A</td>
<td valign="middle" align="left">Schisandra chinensis</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>Human renal glomerular endothelial cells</td>
<td valign="middle" align="left">Inhibited NLRP3 <italic>via</italic> AdipoR1/AMPK-ROS/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B122">122</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Ferulic acid</td>
<td valign="middle" align="left">Tomatoes, sweet corn, rice grain, Cimicifuga racemosa, Angelica sinensis, and ligustici chuanxiong rhizome</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ mice</td>
<td valign="middle" align="left">Inhibited NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B123">123</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Sauchinone</td>
<td valign="middle" align="left">Saururus chinensis</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">Human renal mesangial cells</td>
<td valign="middle" align="left">Inhibited NF-&#x3ba;B, ROS, and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B124">124</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="4" align="left">Others</td>
<td valign="middle" align="left">Crocin</td>
<td valign="middle" align="left">Saffron</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">InhibitedROS and NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B125">125</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Pyrroloquinoline quinone</td>
<td valign="middle" align="left">Fruits, vegetables, Gram-negative bacteria, and human breast milk</td>
<td valign="middle" align="left">
<italic>In vivo, in vitro</italic>
</td>
<td valign="middle" align="left">STZ mice<break/>HK-2 cells</td>
<td valign="middle" align="left">ReducedROS and inhibited NF-&#x3ba;B/NLRP3</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B126">126</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Apocynin</td>
<td valign="middle" align="left">Picrorhiza kurroa</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ Rats</td>
<td valign="middle" align="left">InhibitedNLRP3/XIAP</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B127">127</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Diallyl trisulfide</td>
<td valign="middle" align="left">garlic</td>
<td valign="middle" align="left">
<italic>In vivo</italic>
</td>
<td valign="middle" align="left">STZ rats</td>
<td valign="middle" align="left">InhibitedROS/NLRP3/Caspase-1</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B128">128</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>HFD, high-fat diet; MPC-5, mouse podocyte cell-5; NEK7, never in mitosis A-related kinase 7; PAR-1, protease-activated receptor 1; STZ, streptozotocin; XIAP, X-linked inhibitor of apoptosis protein.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Natural products in alleviating DKD by targeting the NLRP3 inflammasome.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1196016-g001.tif"/>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Mechanism of natural products alleviating DKD by targeting NLRP3 inflammasome.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1196016-g002.tif"/>
</fig>
<sec id="s4_1">
<label>4.1</label>
<title>Flavonoids</title>
<p>Flavonoids refer to a series of compounds formed by two benzene rings connected to each other by three carbon atoms, that is, with a C<sub>6</sub>-C<sub>3</sub>-C<sub>6</sub> structure (<xref ref-type="bibr" rid="B129">129</xref>). Natural flavonoids are classified based on their basic structure into flavones, flavanones, isoflavones, flavonols, anthocyanins, and flavan-3-ols. They are widely found in plants.</p>
<p>Naringin is a bioflavonoid mainly found in the fruits of Citrus paradisi Macfadyen, grapefruit, tangerine, and oranges. It appears to have antioxidant, anticancer, and anti-atherosclerosis properties. It is reported that naringin could lower glucose levels (<xref ref-type="bibr" rid="B130">130</xref>&#x2013;<xref ref-type="bibr" rid="B132">132</xref>). In rat glomerular mesangial cells induced by HG, the expressions of NLRP3 were significantly higher. Pre-treatment with naringin alleviated the activation of NLRP3 inflammasome, and inhibited cell proliferation (<xref ref-type="bibr" rid="B81">81</xref>).</p>
<p>Quercetin (Qu) is a plant flavonoid widely exist in apples, grapes, tomatoes, and onions, etc. Its structure contains phenolic hydroxyl groups and double bonds, which provide strong antioxidant activity (<xref ref-type="bibr" rid="B133">133</xref>). Dihydroquercetin (DHQ), also known as taxifolin, is the reduced form of Qu. It is a major dihydroflavone compound derived from Larix sibirica Ledeb. and Pseudotsuga taxifolia (Lamb.) Britton (<xref ref-type="bibr" rid="B134">134</xref>). These two natural compounds exert numerous biological activities, including antioxidant, anti-inflammation, antitumor, antiviral effects (<xref ref-type="bibr" rid="B135">135</xref>&#x2013;<xref ref-type="bibr" rid="B139">139</xref>). Wang et&#xa0;al. (<xref ref-type="bibr" rid="B82">82</xref>) found that Qu can suppress the NLRP3 inflammasome activation in kidney, ameliorating kidney lipid accumulation in STZ-treated rats. A meta-analysis of rodent data (<xref ref-type="bibr" rid="B140">140</xref>) also showed that Qu significantly improved renal function, urinary protein excretion, and renal pathological changes in DKD. Regarding the underlying mechanisms, Qu may provide renoprotection in DKD through the mtROS-TRX/TXNIP/NLRP3/IL-1&#x3b2; pathways. For DHQ, it has been shown to significantly reduce microalbuminuria, improve glucose and lipid metabolism dysfunction, and alleviate renal pathological changes in DKD rats. In renal cells induced by HG, DHQ significantly inhibits the activation of NLRP3 inflammasomes and renal fibrosis-associated proteins, reducing cell proliferation and oxidative stress (<xref ref-type="bibr" rid="B83">83</xref>).</p>
<p>Fisetin is a natural flavonol extracted from many fruits and vegetables, such as strawberries, apples, cucumbers, and onions (<xref ref-type="bibr" rid="B84">84</xref>). Studies indicate that fisetin possesses anti-inflammatory, anti-oxidant, anti-tumor, and cardiovascular protective effect (<xref ref-type="bibr" rid="B141">141</xref>&#x2013;<xref ref-type="bibr" rid="B143">143</xref>). Dong et&#xa0;al. (<xref ref-type="bibr" rid="B84">84</xref>) demonstrated that fisetin ameliorated podocyte injury caused by HG, and mitigated renal injury in diabetic mice by suppressing NLRP3 inflammasome. Ge et&#xa0;al. (<xref ref-type="bibr" rid="B85">85</xref>) found that fisetin significantly attenuated the kidney damage in DKD mice, accompanied by a noticeable reduction in NLRP3 expression in the kidney. The protective effects of fisetin against DKD were also confirmed <italic>in vitro</italic> using palmitate-treated HK2 cells.</p>
<p>Liquiritigenin and Isoliquiritigenin (ISLQ) are flavonoid compounds extracted from Glycyrrhiza radix. Convincing evidence has shown that liquiritigenin and ISLQ possess a diversity of biological properties, such as anti-inflammatory, anti-oxidative, anti-hyperlipidemic, anti-tumor, and hepato-protective efficacity (<xref ref-type="bibr" rid="B144">144</xref>&#x2013;<xref ref-type="bibr" rid="B148">148</xref>). Zhu et&#xa0;al. (<xref ref-type="bibr" rid="B86">86</xref>) found that liquiritigenin inhibited HG-induced extra-cellular matrix accumulation in glomerular mesangial cells. Moreover, liquiritigenin decreased HG-induced oxidative stress and inflammatory response <italic>via</italic> suppressing NF-&#x3ba;B/NLRP3 pathways. Alzahrani et&#xa0;al. (<xref ref-type="bibr" rid="B87">87</xref>) found that in DKD rats, ISLQ protected renal function and attenuated inflammation and collagen formation in kidney by restoring the Sirt-1/NF-&#x3ba;B balance, and downregulating NLRP3 expression.</p>
<p>Icariin (ICA) is obtained from Herba epimedii, and exerts quite a few pharmacological effects, such as anti-fibrosis and anti-inflammation (<xref ref-type="bibr" rid="B149">149</xref>). Ding et&#xa0;al. (<xref ref-type="bibr" rid="B26">26</xref>) confirmed that ICA increases Sesn2-induced mitophagy to inhibit NLRP3 inflammasome activation by the Keap1-Nrf2/HO-1 signaling pathway in DKD rats.</p>
<p>Calycosin is a representative isoflavone extracted from Radix Astragali (<xref ref-type="bibr" rid="B150">150</xref>). Many animal models have demonstrated that calycosin has reno-protective property (<xref ref-type="bibr" rid="B151">151</xref>). In diabetic SD rats, calycosin improves the deteriorated kidney functions and proteinuria. The possible mechanism is by regulating NF-&#x3ba;B/p65/NLRP3/TXNIP pathway (<xref ref-type="bibr" rid="B88">88</xref>).</p>
<p>Luteolin is a natural flavonoid present in several fruits and vegetables. It possesses many pharmacological properties, such as anti-inflammatory, antioxidant, anti-apoptotic, and anti-cancer effects (<xref ref-type="bibr" rid="B152">152</xref>&#x2013;<xref ref-type="bibr" rid="B154">154</xref>). Yu et&#xa0;al. (<xref ref-type="bibr" rid="B89">89</xref>) revealed that luteolin could reduce cell apoptotic in HG-treated podocyte, and significantly inhibit the NLRP3 inflammasome activation and IL-1&#x3b2; production in HG-treated MPC-5 cells, suggesting that the anti-apoptotic effect was mostly related to NLRP3 inflammasome.</p>
<p>Complanatoside A (CA) is the ethanolic extract of Semen Astragali Complanati. It exhibits several biological activities, such as anti-oxidant and anti-apoptosis (<xref ref-type="bibr" rid="B155">155</xref>), and is widely used to fight against renal diseases in China. Ren et&#xa0;al. (<xref ref-type="bibr" rid="B90">90</xref>) found that CA mitigated the pathological lesions of glomeruli and tubular interstitium in DKD mice, it also reduced epithelial-mesenchymal transition (EMT) of HK-2 cells <italic>via</italic> blocking NOX4 expression and NLRP3 inflammasome activation.</p>
<p>Kaempferol is a natural compound with the formula C<sub>15</sub>H<sub>10</sub>O<sub>6</sub>. It is mainly derived from the roots and stems of sand ginger, and is also distributed in plants such as tea, broccoli, and grapefruit. It is reported that kaempferol has antibacterial, anti-inflammatory, antioxidant, antitumor and many other pharmacological effects (<xref ref-type="bibr" rid="B156">156</xref>, <xref ref-type="bibr" rid="B157">157</xref>). Studies revealed that kaempferol improved proteinuria and renal function in DKD rats. It also relieved renal tissue damage and cell apoptosis. Since the expression of NLRP3, ASC, and caspase-1 was decreased, it is probable that kaempferol can alleviate kidney damage in DKD rats by inhibiting the NLRP3 inflammasome (<xref ref-type="bibr" rid="B91">91</xref>).</p>
<p>Carithamine is a natural flavochrome extracted from the petals of safflower that has a variety of pharmacological properties, such as dilating coronary arteries, protecting myocardium and brain tissue, antioxidant, and immunoregulation (<xref ref-type="bibr" rid="B158">158</xref>). Gao et&#xa0;al. (<xref ref-type="bibr" rid="B92">92</xref>) found that intraperitoneal injection of carithamine alleviated proteinuria in DKD rats by downregulating the expression of NLRP3 and Caspase-1.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Saponins</title>
<p>Saponins are a class of glycosides whose aglycones are triterpenoids or spirostanes. They are mainly found in terrestrial higher plants but can also be found in marine organisms such as starfish and sea cucumbers (<xref ref-type="bibr" rid="B159">159</xref>). Saponins are generally considered beneficial for the cardiovascular system and diabetes (<xref ref-type="bibr" rid="B160">160</xref>).</p>
<p>Ginsenoside is the major active constituent of ginseng, which belongs to perennial herbaceous plant and is used as a traditional herb medicine for many years (<xref ref-type="bibr" rid="B161">161</xref>). Ginsenoside owns many biological activities, including anti-inflammation, anti-tumor, and anti-diabetes (<xref ref-type="bibr" rid="B162">162</xref>&#x2013;<xref ref-type="bibr" rid="B164">164</xref>). Ginsenoside Rg1 and Ginsenoside Rg5 are the representative monomers of ginsenoside (<xref ref-type="bibr" rid="B165">165</xref>, <xref ref-type="bibr" rid="B166">166</xref>). Wang et&#xa0;al. (<xref ref-type="bibr" rid="B93">93</xref>) found that ginsenoside Rg1 inhibited pyroptosis in hyperlipid-induced podocytes, and this effect was also observed in the kidneys of rats with DKD. The possible mechanism was by down-regulating the mTOR/NF-&#x3ba;B/NLRP3 pathway. Zhu et&#xa0;al. (<xref ref-type="bibr" rid="B94">94</xref>) demonstrated that ginsenoside Rg5 reduced oxidative stress and the activation of NLRP3 inflammasome, thereby mitigated kidney damage in DKD mice. Ginsenoside compound K(CK) is the final metabolite of diol-type ginsenosides such as Rb1 and Rb2 by the action of intestinal flora (<xref ref-type="bibr" rid="B167">167</xref>). Song et&#xa0;al. (<xref ref-type="bibr" rid="B95">95</xref>) proved that CK significantly improved renal function and urinary protein excretion of DKD mice, and the proliferation of glomerular mesangial matrix was also decreased. Moreover, the protective effect of CK is possibly due to suppression of NF-&#x3ba;B/p38 and ROS/NLRP3 signaling pathway.</p>
<p>Sarsasapogenin (Sar) is a steroidal sapogenin isolated from Anemarrhena asphodeloides Bunge. It is believed to have antiplatelet, antithrombotic, and anti-inflammatory propertis (<xref ref-type="bibr" rid="B168">168</xref>&#x2013;<xref ref-type="bibr" rid="B171">171</xref>). Tang et&#xa0;al. (<xref ref-type="bibr" rid="B96">96</xref>) found that Sar significantly improved kidney function in DKD rats, and renal histopathology showed that it reduced mesangial cell proliferation, inhibited the activation of NLRP3 inflammasome and NF-&#x3ba;B. Liu et&#xa0;al. (<xref ref-type="bibr" rid="B97">97</xref>) also found that Sar can markedly ameliorate DKD in rats <italic>via</italic> ameliorating the NLRP3 inflammasome activation and AGEs&#x2013;receptor for AGE (RAGE) interaction.</p>
<p>Astragaloside IV (AS&#x2212;IV) is the primary active ingredient in Astragalus membranaceus, a traditional herb medicine. It has been identified to have anti-inflammatory and anti-oxidant effects and is widely used to deal with diabetes and cardiovascular diseases (<xref ref-type="bibr" rid="B172">172</xref>, <xref ref-type="bibr" rid="B173">173</xref>). Feng et&#xa0;al. (<xref ref-type="bibr" rid="B98">98</xref>) demonstrated that AS-IV blocked NLRP3 inflammasome activation, and improved renal function and podocytes damage in db/db mice, exerting a reno-protective effect. Zhao et&#xa0;al. (<xref ref-type="bibr" rid="B99">99</xref>) observed that AS&#x2212;IV reduced NLRP3 expression in HG exposed mouse glomerular mesangial cells.</p>
<p>Salidroside (SAL) is the predominant component of Rhodiola rosea, an herbal plant with a wide range of pharmacological effects, including anti-altitude sickness, anti-oxidant, and anti-diabetes (<xref ref-type="bibr" rid="B174">174</xref>&#x2013;<xref ref-type="bibr" rid="B176">176</xref>). SAL also exerts beneficial effects on DKD (<xref ref-type="bibr" rid="B177">177</xref>). Wang et&#xa0;al. (<xref ref-type="bibr" rid="B100">100</xref>) showed that SAL inhibited TXNIP/NLRP3 signaling pathway in rat glomerular mesangial cells.</p>
<p>Notoginsenoside Fc (Fc) is a novel saponin extracted from Panax notoginseng with excellent anti-platelet aggregation ability (<xref ref-type="bibr" rid="B178">178</xref>). It is reported that Fc reduced albuminuria, alleviated renal failure, and relieved podocyte injury in db/db mice by inhibiting the NLRP3 inflammasomes (<xref ref-type="bibr" rid="B101">101</xref>).</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Phenolics</title>
<p>Phenolics are a class of chemicals that contain aromatic rings and hydroxyl groups. They are widely distributed in nature, especially in fruits, vegetables, cereals, flowers, spices, and teas (<xref ref-type="bibr" rid="B179">179</xref>). In the past decades, the potential value of phenolics in healing DKD has been explored.</p>
<p>Tetrahydroxy stilbene glucoside (TSG) is derived from Polygoni Multiflori Radix. TSG has been shown to reduce blood cholesterol, protect the liver, possess antioxidant abilities, and exhibit anti-atherosclerotic properties (<xref ref-type="bibr" rid="B180">180</xref>). Li et&#xa0;al. (<xref ref-type="bibr" rid="B102">102</xref>) demonstrated that TSG prevented podocytes apoptosis in HG condition, and it was partly through the blockade of NLRP3 inflammasome.</p>
<p>Gastrodin is a natural compound isolated from the dried root of Gastrodia elata (<xref ref-type="bibr" rid="B181">181</xref>). It has been found to exert anti-inflammatory, antioxidative, and neuroprotective effects (<xref ref-type="bibr" rid="B182">182</xref>). Huang et&#xa0;al. (<xref ref-type="bibr" rid="B103">103</xref>) proved that gastrodin halted the activation of NLRP3 inflammasome in HG-treated podocytes, which reduced renal inflammation and oxidative stress.</p>
<p>Epigallocatechin-3-gallate (EGCG) is a polyphenolic component found in tea leaves with strong anti-inflammatory property. Yang et&#xa0;al. (<xref ref-type="bibr" rid="B104">104</xref>) confirmed that EGCG can ameliorate renal dysfunction and renal histopathological injury in DKD rats. Furthermore, the reno-protective effects of EGCG are mainly related to the suppression of endoplasmic reticulum stress-mediated NLRP3 inflammasome overactivation.</p>
<p>Resveratrol is a polyphenolic compound mainly derived from plants such as grapes, peanuts, mulberries, and Polygonum cuspidatum (<xref ref-type="bibr" rid="B183">183</xref>). It is reported to be a strong scavenger of ROS (<xref ref-type="bibr" rid="B184">184</xref>), and has the ability to ameliorate hyperglycemia mediated renal dysfunction (<xref ref-type="bibr" rid="B185">185</xref>). Xiao et&#xa0;al. (<xref ref-type="bibr" rid="B105">105</xref>) revealed that in diabetic models with acute kidney injury, the primary mechanism is attributed to TXNIP/NLRP3 activation stimulated by oxidative stress.</p>
<p>Piceatannol is a polyphenol compound sharing a similar chemical structure to resveratrol. It is mainly found in grapes, sugar cane, white tea, rhubarb, passion fruit and blueberries (<xref ref-type="bibr" rid="B186">186</xref>). Piceatannol is considered to have anticancer, anti-atherogenic, anti-oxidative, anti-inflammatory, anti-microbial and estrogenic activities, and is widely used in the treatment of heart disease, leukemia and cancer (<xref ref-type="bibr" rid="B187">187</xref>&#x2013;<xref ref-type="bibr" rid="B190">190</xref>). Yao et&#xa0;al. found that piceatannol can inhibit apoptosis, inflammation and oxidative stress of podocytes under HG condition. The possible mechanism is that it inhibits the activation of NLRP3 inflammation by promoting Nrf2 nuclear translocation and up-regulating Nrf2 expression (<xref ref-type="bibr" rid="B106">106</xref>).</p>
<p>Curcumin, a chief component of Curcuma longa, has been consumed by humans as a spice. It exhibits powerful anti-inflammatory and anti-cancer properties (<xref ref-type="bibr" rid="B191">191</xref>). The reno-protective effect of curcumin in DKD rats has been verified (<xref ref-type="bibr" rid="B192">192</xref>, <xref ref-type="bibr" rid="B193">193</xref>). Lu et&#xa0;al. (<xref ref-type="bibr" rid="B107">107</xref>) found that curcumin inhibited the activation of NLRP3 inflammasome in db/db mice, similar to that in HG-induced HK-2 cells, resulting in alleviation of DKD.</p>
<p>Punicalagin (PU) is the main component of pomegranate polyphenols and is found abundantly in pomegranate, myrobalan, leaves of yellow wood, and tropical almond (<xref ref-type="bibr" rid="B194">194</xref>, <xref ref-type="bibr" rid="B195">195</xref>). PU exhibits strong antioxidative, anti-inflammatory, and antineoplastic properties (<xref ref-type="bibr" rid="B196">196</xref>, <xref ref-type="bibr" rid="B197">197</xref>). An et&#xa0;al. (<xref ref-type="bibr" rid="B108">108</xref>) proved that PU reduced kidney damage in high-fat diet (HFD)/streptozotocin (STZ) mice, possibly by downregulating the NOX4/TXNIP/NLRP3 pathway.</p>
<p>Purple Sweet Potato Color (PSPC) is a natural flavonoid leached from the rhizome of purple sweet potatoes. It has strong anti-oxidant and anti-inflammatory abilities that can protect the brain, liver, and kidney (<xref ref-type="bibr" rid="B198">198</xref>&#x2013;<xref ref-type="bibr" rid="B200">200</xref>). Zheng et&#xa0;al. (<xref ref-type="bibr" rid="B109">109</xref>) found that PSPC exert renal protection in HFD-treated mice by inhibiting ROS-Triggered NRLP3 inflammation.</p>
<p>Grape seed proanthocyanidin is a polyphenol compound extracted from grape seeds, which is one of the most efficient antioxidants found to date. It has anti-radiation, anti-cancer, anti-atherosclerosis and anti-diabetic effects (<xref ref-type="bibr" rid="B201">201</xref>&#x2013;<xref ref-type="bibr" rid="B203">203</xref>). Qiu et&#xa0;al. (<xref ref-type="bibr" rid="B110">110</xref>) found that in DKD rats with ischemia-reperfusion injury, intraperitoneal injection of grape seed proanthocyanidin could improve renal function and alleviate renal oxidative stress, possibly by inhibiting NLRP3 gene expression.</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Terpenoids</title>
<p>Terpenoids are olefin compounds with an isoprene unit (C<sub>5</sub> unit) as the basic structural unit. They exist widely in nature and are the main components of some plant fragrances, resins and pigments. Terpenoids have diverse physicochemical properties and biological activities, and exhibit promising efficacy in the management of DKD (<xref ref-type="bibr" rid="B204">204</xref>).</p>
<p>Pristimerin (Pri) is a quinonoid triterpene isolated from Celastraceae and Hippocrateaceae (<xref ref-type="bibr" rid="B205">205</xref>). It shows excellent anti-bacterial, anti-fungal, anti-inflammatory, and anti-tumor abilities (<xref ref-type="bibr" rid="B206">206</xref>, <xref ref-type="bibr" rid="B207">207</xref>), and has been widely used in treating colitis, sepsis, and neuroinflammation (<xref ref-type="bibr" rid="B208">208</xref>, <xref ref-type="bibr" rid="B209">209</xref>). Zhao et&#xa0;al. (<xref ref-type="bibr" rid="B111">111</xref>) found that intraperitoneal injection of Pri in an HFD-induced diabetic mouse model reversed metabolic disorders by restraining the activation of the NLRP3 inflammasome. They further illustrated that this was associated with disturbing the interaction between never in mitosis A-related kinase 7 (NEK7) and NLRP3 <italic>in vitro</italic>.</p>
<p>Geniposide (GE) and genipin-1-&#x3b2;-d-gentiobioside (GG) are active ingredients extracted from the fruit of Gardenia jasminoides Ellis. Many researches on GE have proved that it can lower blood glucose and lose weight, it also has anti-inflammatory, anti-tumor, neuroprotective, and myocardial protective effects (<xref ref-type="bibr" rid="B210">210</xref>&#x2013;<xref ref-type="bibr" rid="B212">212</xref>). Hu et&#xa0;al. (<xref ref-type="bibr" rid="B213">213</xref>) revealed that GE can alleviated the development of STZ-induced DKD. Li et&#xa0;al. (<xref ref-type="bibr" rid="B112">112</xref>) confirmed that GE down-regulated the expression of NLRP3, ASC, IL-1, and Caspase-1&#x3b2; in DKD mice, possibly through down-regulation of the AMPK/SIRT1/NF-&#x3ba;B signaling pathway. GG has a chemical structure similar to that of GE, except for one more glycosidic group. Li et&#xa0;al. (<xref ref-type="bibr" rid="B63">63</xref>) suggested that GG promoted podocyte survival and attenuated renal damage in DKD mice, with the reno-protective effect related to the AMPK/SIRT1/NF-&#x3ba;B/NLRP3 pathway.</p>
<p>Swietenine (Swi) is derived from the Swietenia macrophylla King plant and possesses outstanding anti-bacterial, anti-inflammatory, anti-oxidant, anti-tumor, and anti-diabetic properties (<xref ref-type="bibr" rid="B214">214</xref>&#x2013;<xref ref-type="bibr" rid="B216">216</xref>). Duan et&#xa0;al. (<xref ref-type="bibr" rid="B113">113</xref>) found that Swi remarkably improved renal function and suppressed inflammatory response in DKD mice. The signal pathway that may be involved is NF-&#x3ba;B/NLRP3/Caspase-1 axis.</p>
<p>Artesunate (ART) is a major derivative of artemisinin isolated from Artemisia annua (<xref ref-type="bibr" rid="B217">217</xref>). Studies have revealed that ART possesses a wide range of biological activities, including anti-malarial, anti-oxidative, anti-inflammatory, and anti-tumor effects (<xref ref-type="bibr" rid="B218">218</xref>&#x2013;<xref ref-type="bibr" rid="B220">220</xref>). Sun et&#xa0;al. (<xref ref-type="bibr" rid="B114">114</xref>) demonstrated that ART inhibited TLR4/NF-&#x3ba;B/NLRP3 pathway, thereby ameliorating glomerular mesangial cell injury under HG conditions.</p>
<p>Catalpol (Cat) is an iridoid glycoside rich in the roots of Rehmannia glutinosa, exhibiting potent anti-oxidant, anti-tumor, anti-inflammatory, and anti-diabetic effects (<xref ref-type="bibr" rid="B221">221</xref>, <xref ref-type="bibr" rid="B222">222</xref>). There are accumulating evidence suggesting that Cat can be used to treat DKD (<xref ref-type="bibr" rid="B223">223</xref>). Chen et&#xa0;al. (<xref ref-type="bibr" rid="B115">115</xref>) revealed that Cat effectively attenuated kidney damage in DKD mice, it can reduce oxide stress and inflammation by targeting AMPK/SIRT1/NF-&#x3ba;B pathway.</p>
<p>Andrographolide is a labdane diterpenoid isolated from Andrographis paniculata Nees with numerous biological activities, including anti-inflammatory, anti-tumor, and anti-diabetic capacities (<xref ref-type="bibr" rid="B224">224</xref>). Li et&#xa0;al. (<xref ref-type="bibr" rid="B225">225</xref>) found that andrographolide attenuated DKD progression by inhibiting oxidative stress and inflammation in mesangial cells. Moreover, they found that andrographolide significantly reduced HG-induced apoptosis, EMT, and fibrosis <italic>via</italic> blocking NLRP3 inflammasome activation (<xref ref-type="bibr" rid="B116">116</xref>).</p>
<p>Triptolide (TP) is the main active ingredient isolated from Tripterygium wilfordii Hook F. It exhibits excellent anti-inflammatory and anti-apoptosis abilities, as well as anti-cancer and anti-diabetic activities (<xref ref-type="bibr" rid="B226">226</xref>&#x2013;<xref ref-type="bibr" rid="B228">228</xref>). Wu et&#xa0;al. (<xref ref-type="bibr" rid="B117">117</xref>) discovered that TP can block the activation of NLRP3 inflammasome and alleviate EMT in podocytes under HG condition, which may be one of the mechanisms by which TP alleviates podocytes injury in DKD.</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>Alkaloids</title>
<p>Alkaloids are a class of nitrogen-containing basic organic compounds, which mainly exist in plant. Alkaloids have abundant medicinal value, possessing anti-arrhythmia, anti-hypertensive, analgesic, anti-inflammatory, and anti-cancer properties (<xref ref-type="bibr" rid="B229">229</xref>, <xref ref-type="bibr" rid="B230">230</xref>).</p>
<p>Berberine (BBR), also known as berberine hydrochloride or berberine sulphate, is an alkaloid derived from Coptis. It shows anti-inflammatory, anti-oxidant, anti-diabetic, and hypolipidemic activities (<xref ref-type="bibr" rid="B231">231</xref>). It is reported that BBR relieves DKD by inhibiting mesangial cell proliferation and ameliorating tubulointerstitial fibrosis (<xref ref-type="bibr" rid="B232">232</xref>, <xref ref-type="bibr" rid="B233">233</xref>). Ding et&#xa0;al. (<xref ref-type="bibr" rid="B28">28</xref>) revealed that BBR can reduce oxidative stress and antagonize inflammation by regulating Nrf2/NLRP3 pathway. Ma et&#xa0;al. (<xref ref-type="bibr" rid="B118">118</xref>) also confirmed that BBR could inhibit HG induced EMT and renal interstitial fibrosis by down-regulating the NLRP3 inflammasome in HK-2 cells.</p>
<p>Piperine (Pip) is a bioactive alkaloid mainly present in black pepper. It has many pharmaceutical effects including promoting digestion, lowering lipid peroxidation, as well as anti-inflammatory, anti-cancer, and antioxidant (<xref ref-type="bibr" rid="B234">234</xref>&#x2013;<xref ref-type="bibr" rid="B236">236</xref>). Cepharanthine (CEP) is a natural alkaloid extracted from Stephania cepharantha Hayata, and possesses anti-oxidative, anti-inflammatory, anti-proliferative, anti-metastatic and anti-atherosclerosis properties (<xref ref-type="bibr" rid="B237">237</xref>, <xref ref-type="bibr" rid="B238">238</xref>). Samra et&#xa0;al. (<xref ref-type="bibr" rid="B119">119</xref>) found that CEP, Pip or their combination noticeably improves renal function and proteinuria in diabetic rats, accompanied by down-regulation of NF-&#x3ba;B and NLRP3.</p>
<p>Solasonine (SS) is a natural glycoalkaloid isolated from Solanummelongena. It has been proved to possess anti&#x2010;inflammatory, anti-cancer, and neuroprotective properties (<xref ref-type="bibr" rid="B239">239</xref>&#x2013;<xref ref-type="bibr" rid="B241">241</xref>). Zhang et&#xa0;al. (<xref ref-type="bibr" rid="B120">120</xref>) revealed that SS alleviated cell apoptosis, reduced pyroptosis and oxidative injury in podocytes induced by HG. The possible mechanism may be through regulating the Nrf2/NLRP3 signaling pathway.</p>
<p>Rutaecarpine is an important active component of Euodia rutaecarpine (<xref ref-type="bibr" rid="B242">242</xref>). Numerous studies have shown that rutaecarpine has anti-inflammatory, anti-atherosclerosis, and anti-cancer pharmacological effects (<xref ref-type="bibr" rid="B243">243</xref>&#x2013;<xref ref-type="bibr" rid="B245">245</xref>). Hu et&#xa0;al. (<xref ref-type="bibr" rid="B121">121</xref>) found that rutaecarpine effectively alleviated renal damage in db/db mice, along with the reduced expression of NLRP3/ASC/IL-18/IL-1&#x3b2; in the kidney. <italic>In vitro</italic> studies also confirmed that rutaecarpine can inhibit NLRP3/ASC/IL-18/IL-1&#x3b2; in MPC-5 and reduce programmed cell necrosis, which suggested that rutaecarpine may be protective to DKD through NLRP3-dependent pathway.</p>
</sec>
<sec id="s4_6">
<label>4.6</label>
<title>Phenylpropanoids</title>
<p>Phenylpropanoids are one of the main phenolic acids widely distribution in plants, with the C6-C3 carbon skeleton as core structure (<xref ref-type="bibr" rid="B246">246</xref>). They are mainly found in fruits, vegetables, cereal grains, beverages, spices and herbs. Phenylpropanoids are known to have multifaceted effects, including antimicrobial, antioxidant, anti-inflammatory, anti-diabetic, anticancer activities (<xref ref-type="bibr" rid="B247">247</xref>, <xref ref-type="bibr" rid="B248">248</xref>). Their therapeutic effects on DKD are also being explored.</p>
<p>Schisandra chinensis is the dried ripe fruits of Schisandra chinensis (Turcz.) Baill. It is both a health food and a traditional herb medicine (<xref ref-type="bibr" rid="B249">249</xref>, <xref ref-type="bibr" rid="B250">250</xref>).. Schisandrin A is the main lignan derived from Schisandra chinensis, which exerts anti-oxidative, anti-apoptosis, and sedative abilities (<xref ref-type="bibr" rid="B251">251</xref>, <xref ref-type="bibr" rid="B252">252</xref>). Wang et&#xa0;al. (<xref ref-type="bibr" rid="B122">122</xref>) revealed that schisandrin A decreased ROS overproduction and inhibited inflammation in DKD mice. It also reduced HG-induced ferroptosis and ROS-mediated pyroptosis by mitochondrial damage in human renal glomerular endothelial cells. The expression of TXNIP and NLRP3 was down-regulated by Schisandrin A, suggesting that Schisandrin A attenuated DKD by suppressing TXNIP/NLRP3 signaling pathway.</p>
<p>Ferulic acid (FA) is a natural derivative of caffeic acid commonly found in vegetables, especially in tomatoes, corns, and rices. It is also the main active ingredient of many traditional herbal medicines, involving Cimicifuga racemosa, Angelica sinensis, and ligustici chuanxiong rhizome (<xref ref-type="bibr" rid="B253">253</xref>). FA exhibits a wide range of therapeutic effects, including scavenging free radicals, antioxidant properties, and anti-cancer, anti-inflammatory, anti-fibrotic, and reno-protective effects against cardiovascular diseases, neurodegenerative diseases, and diabetes (<xref ref-type="bibr" rid="B253">253</xref>&#x2013;<xref ref-type="bibr" rid="B256">256</xref>). It is also revealed that FA has reno-protective effects in DKD rats by antioxidation, anti-inflammation and anti-fibrosis (<xref ref-type="bibr" rid="B257">257</xref>&#x2013;<xref ref-type="bibr" rid="B259">259</xref>). Ma et&#xa0;al. (<xref ref-type="bibr" rid="B123">123</xref>) further proved that FA reduced the expressions of p62, NLRP3 and IL-1&#x3b2; in renal tissues of DKD mice and suppressed inflammation.</p>
<p>Sauchinone is a biologically active lignin extracted from Saururus chinensis. Studies have shown that it has powerful anti-oxidant, anti-inflammatory, anti-apoptosis, anti-cancer and anti-obesity abilities (<xref ref-type="bibr" rid="B260">260</xref>&#x2013;<xref ref-type="bibr" rid="B263">263</xref>). Yoon et&#xa0;al. (<xref ref-type="bibr" rid="B124">124</xref>) found that sauchinone improved angiotensin II-induced mesangial inflammation by inhibiting the NLRP3 inflammasome.</p>
</sec>
<sec id="s4_7">
<label>4.7</label>
<title>Others</title>
<p>Crocin is a carotenoid compound mainly exist in saffron, which belongs to the iris family, a perennial stemless herb. Previous studies have shown that crocin has a variety of pharmacological effects, including the inhibition of cancer growth, inflammatory responses, apoptosis, and oxidative stress (<xref ref-type="bibr" rid="B264">264</xref>&#x2013;<xref ref-type="bibr" rid="B268">268</xref>). Crocin also has reno-protective effects (<xref ref-type="bibr" rid="B269">269</xref>). Zhang et&#xa0;al. (<xref ref-type="bibr" rid="B125">125</xref>) demonstrated that Crocin improved diabetic kidney dysfunction and renal fibrosis in STZ rat. Additionally, Crocin reduced excessive ROS production and decreased the synthesis of pro-inflammatory factors by inhibiting the activation of the NLRP3 inflammasome.</p>
<p>Pyrroloquinoline quinone (PQQ) is the third coenzyme of oxidoreductase discovered so far, which exists widely in plants, bacteria, animals, and human (<xref ref-type="bibr" rid="B270">270</xref>). The confirmed biological abilities of PQQ include antioxidant, neuro-protection, and immunoregulation (<xref ref-type="bibr" rid="B271">271</xref>&#x2013;<xref ref-type="bibr" rid="B273">273</xref>). Qu et&#xa0;al. (<xref ref-type="bibr" rid="B126">126</xref>) demonstrated that PQQ down-regulated the expression of NLRP3, caspase-1, IL-1&#x3b2;, and attenuated renal fibrosis by alleviating mitochondrial dysfunction, reducing ROS production in STZ mice and HG induced HK-2 cells.</p>
<p>Apocynin is a compound isolated from the root of the medicinal herb Picrorhiza kurroa (<xref ref-type="bibr" rid="B274">274</xref>, <xref ref-type="bibr" rid="B275">275</xref>). It is used as an antioxidant due to the ability to inhibit NADPH oxidase activity and reduce ROS production (<xref ref-type="bibr" rid="B276">276</xref>, <xref ref-type="bibr" rid="B277">277</xref>). Xin et&#xa0;al. (<xref ref-type="bibr" rid="B127">127</xref>) found that in rats with DKD, apocynin improved renal function and attenuated renal fibrosis. This effect was likely due to the down-regulation of the NLRP3/X-linked inhibitor of apoptosis protein (XIAP) signaling pathway.</p>
<p>Diallyl trisulfide (DATS), one of the main allyl sulfur compounds exist in garlic, possesses considerable anti-oxidant, anti-inflammatory, anti-fibrosis, and anti-fungal activities (<xref ref-type="bibr" rid="B278">278</xref>&#x2013;<xref ref-type="bibr" rid="B280">280</xref>). Shen et&#xa0;al. (<xref ref-type="bibr" rid="B128">128</xref>) confirmed that DATS alleviated renal damage in DKD rats, and the expressions of ROS, NLRP3, ASC, Caspase-1, IL-1&#x3b2; and IL-18 were decreased, which suggested that DATS may be effective in treating DKD by inhibiting ROS/NLRP3/Caspase-1 pathway.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusion">
<label>5</label>
<title>Conclusion</title>
<p>Inflammation plays a crucial role in the pathogenesis of DKD, and the NLRP3 inflammasome is regarded as a key regulator of inflammation in DKD. Various signaling pathways are involved in the activation of NLRP3 inflammasome, including NF-&#x3ba;B, ROS/TXNIP, ncRNAs. However, specific mechanisms and crosstalk between them require further investigation. Many natural products exhibit excellent anti-inflammatory properties, and may alleviate DKD by inhibiting the activation of NLRP3 inflammasome. However, most studies are mainly limited to <italic>in vitro</italic> and animal experiments. With improved understanding of the regulatory network of NLRP3 inflammasome, and better understanding of the pharmacological mechanism of natural products, more clinical trials on the use of natural products in the treatment of DKD are expected in the future.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>All authors contributed significantly to this work and approved the publication of the manuscript. PL devised the research plan. YW, ZS, and MW wrote the manuscript. PL and YW modified and polished the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>This review was supported by the Research Projects of the National Natural Science Foundation of China (No. 82274489).</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saran</surname> <given-names>R</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>B</given-names>
</name>
<name>
<surname>Abbott</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Bragg-Gresham</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gipson</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>US Renal data system 2019 annual data report: epidemiology of kidney disease in the united states</article-title>. <source>Am J Kidney Dis</source> (<year>2020</year>) <volume>75</volume>(<supplement>1 Suppl 1</supplement>):<page-range>A6&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.ajkd.2019.09.003</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niewczas</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Pavkov</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Skupien</surname> <given-names>J</given-names>
</name>
<name>
<surname>Smiles</surname> <given-names>A</given-names>
</name>
<name>
<surname>Md Dom</surname> <given-names>ZI</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes</article-title>. <source>Nat Med</source> (<year>2019</year>) <volume>25</volume>(<issue>5</issue>):<page-range>805&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41591-019-0415-5</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>T</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Excessive activation of notch signaling in macrophages promote kidney inflammation, fibrosis, and necroptosis</article-title>. <source>Front Immunol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>835879</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.835879</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>SCW</given-names>
</name>
<name>
<surname>Yiu</surname> <given-names>WH</given-names>
</name>
</person-group>. <article-title>Innate immunity in diabetic kidney disease</article-title>. <source>Nat Rev Nephrol</source> (<year>2020</year>) <volume>16</volume>(<issue>4</issue>):<page-range>206&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41581-019-0234-4</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues</surname> <given-names>T</given-names>
</name>
<name>
<surname>Reker</surname> <given-names>D</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>P</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Counting on natural products for drug design</article-title>. <source>Nat Chem</source> (<year>2016</year>) <volume>8</volume>(<issue>6</issue>):<page-range>531&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nchem.2479</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular mechanistic pathways targeted by natural compounds in the prevention and treatment of diabetic kidney disease</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>(<issue>19</issue>):<fpage>6221</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27196221</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Cliff</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>K</given-names>
</name>
<name>
<surname>Squires</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Hills</surname> <given-names>CE</given-names>
</name>
</person-group>. <article-title>The role of the NLRP3 inflammasome in mediating glomerular and tubular injury in diabetic nephropathy</article-title>. <source>Front Physiol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>907504</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphys.2022.907504</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>LQ</given-names>
</name>
</person-group>. <article-title>Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy</article-title>. <source>Pharmacol Res</source> (<year>2016</year>) <volume>114</volume>:<page-range>251&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2016.11.004</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahzad</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fatima</surname> <given-names>S</given-names>
</name>
<name>
<surname>Khawaja</surname> <given-names>H</given-names>
</name>
<name>
<surname>Elwakiel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gadi</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ambreen</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease</article-title>. <source>Kidney Int</source> (<year>2022</year>) <volume>102</volume>(<issue>4</issue>):<page-range>766&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.kint.2022.06.010</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Han</surname> <given-names>W</given-names>
</name>
<name>
<surname>Song</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy</article-title>. <source>Metabolism</source> (<year>2021</year>) <volume>118</volume>:<elocation-id>154748</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.metabol.2021.154748</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Toll-like receptors: sensing and reacting to diabetic injury in the kidney</article-title>. <source>Nephrol Dial Transplant</source> (<year>2014</year>) <volume>29</volume>(<issue>4</issue>):<page-range>746&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ndt/gft446</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Man</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Kanneganti</surname> <given-names>TD</given-names>
</name>
</person-group>. <article-title>Regulation of inflammasome activation</article-title>. <source>Immunol Rev</source> (<year>2015</year>) <volume>265</volume>(<issue>1</issue>):<fpage>6</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12296</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>732933</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.732933</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>F</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Knockdown of TLR4 attenuates high glucose-induced podocyte injury <italic>via</italic> the NALP3/ASC/Caspase-1 signaling pathway</article-title>. <source>BioMed Pharmacother</source> (<year>2018</year>) <volume>107</volume>:<page-range>1393&#x2013;401</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2018.08.134</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>TLR9 regulates NLRP3 inflammasome activation <italic>via</italic> the NF-kB signaling pathway in diabetic nephropathy</article-title>. <source>Diabetol Metab Syndr</source> (<year>2022</year>) <volume>14</volume>(<issue>1</issue>):<fpage>26</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13098-021-00780-y</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mi</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>FOXM1-activated SIRT4 inhibits NF-kappaB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy</article-title>. <source>Exp Cell Res</source> (<year>2021</year>) <volume>408</volume>(<issue>2</issue>):<elocation-id>112863</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yexcr.2021.112863</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<name>
<surname>Song</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>The CXCL1-CXCR2 axis mediates tubular injury in diabetic nephropathy through the regulation of the inflammatory response</article-title>. <source>Front Physiol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>782677</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphys.2021.782677</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dou</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Role of the thioredoxin interacting protein in diabetic nephropathy and the mechanism of regulating NOD&#x2212;like receptor protein 3 inflammatory corpuscle</article-title>. <source>Int J Mol Med</source> (<year>2019</year>) <volume>43</volume>(<issue>6</issue>):<page-range>2440&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijmm.2019.4163</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>P</given-names>
</name>
<name>
<surname>He</surname> <given-names>FF</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>CT</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>XF</given-names>
</name>
<etal/>
</person-group>. <article-title>NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia</article-title>. <source>J Diabetes Res</source> (<year>2015</year>) <volume>2015</volume>:<elocation-id>504761</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2015/504761</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gou</surname> <given-names>F</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>High glucose and lipopolysaccharide prime NLRP3 inflammasome <italic>via</italic> ROS/TXNIP pathway in mesangial cells</article-title>. <source>J Diabetes Res</source> (<year>2016</year>) <volume>2016</volume>:<elocation-id>6973175</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/6973175</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-txnip-nlrp3 biological axis</article-title>. <source>Redox Biol</source> (<year>2018</year>) <volume>16</volume>:<fpage>32</fpage>&#x2013;<lpage>46</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.redox.2018.02.013</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Endoplasmic reticulum stress related factor IRE1alpha regulates TXNIP/NLRP3-mediated pyroptosis in diabetic nephropathy</article-title>. <source>Exp Cell Res</source> (<year>2020</year>) <volume>396</volume>(<issue>2</issue>):<elocation-id>112293</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yexcr.2020.112293</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy</article-title>. <source>Redox Biol</source> (<year>2021</year>) <volume>45</volume>:<elocation-id>102033</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.redox.2021.102033</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>S-S</given-names>
</name>
</person-group>. <source>Sphk2 promotes diabetic nephropathy through regulation of renal tubular epithelial cells injury</source>. <publisher-loc>Guangzhou, Guangdong, China</publisher-loc>: <publisher-name>Guangdong Pharmaceutical University</publisher-name> (<year>2019</year>).</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>P</given-names>
</name>
<name>
<surname>An</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The role of NOX4 in regulating NALP3 inflammasome expression in high glucose-induced podocyte apoptosis</article-title>. <source>Henan Med Res</source> (<year>2019</year>) <volume>28</volume>(<issue>10</issue>):<page-range>1729&#x2013;33</page-range>.</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qiao</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Icariin protects podocytes from NLRP3 activation by Sesn2-induced mitophagy through the Keap1-Nrf2/HO-1 axis in diabetic nephropathy</article-title>. <source>Phytomedicine</source> (<year>2022</year>) <volume>99</volume>:<elocation-id>154005</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2022.154005</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahzad</surname> <given-names>K</given-names>
</name>
<name>
<surname>Bock</surname> <given-names>F</given-names>
</name>
<name>
<surname>Al-Dabet</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Gadi</surname> <given-names>I</given-names>
</name>
<name>
<surname>Nazir</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<elocation-id>34228</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep34228</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>B</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Berberine reduces renal cell pyroptosis in golden hamsters with diabetic nephropathy through the Nrf2-NLRP3-Caspase-1-GSDMD pathway</article-title>. <source>Evid Based Complement Alternat Med</source> (<year>2021</year>) <volume>2021</volume>:<elocation-id>5545193</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2021/5545193</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abd El-Khalik</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Nasif</surname> <given-names>E</given-names>
</name>
<name>
<surname>Arakeep</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Rabah</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>The prospective ameliorative role of zinc oxide nanoparticles in STZ-induced diabetic nephropathy in rats: mechanistic targeting of autophagy and regulating Nrf2/TXNIP/NLRP3 inflammasome signaling</article-title>. <source>Biol Trace Elem Res</source> (<year>2022</year>) <volume>200</volume>(<issue>4</issue>):<page-range>1677&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12011-021-02773-4</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Han</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Qiao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>CD36 promotes NLRP3 inflammasome activation <italic>via</italic> the mtROS pathway in renal tubular epithelial cells of diabetic kidneys</article-title>. <source>Cell Death Dis</source> (<year>2021</year>) <volume>12</volume>(<issue>6</issue>):<fpage>523</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-021-03813-6</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rana</surname> <given-names>R</given-names>
</name>
<name>
<surname>Manoharan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gupta</surname> <given-names>D</given-names>
</name>
<name>
<surname>Elwakiel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Khawaja</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Activated protein c ameliorates tubular mitochondrial reactive oxygen species and inflammation in diabetic kidney disease</article-title>. <source>Nutrients</source> (<year>2022</year>) <volume>14</volume>(<issue>15</issue>):<fpage>3138</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu14153138</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>F</given-names>
</name>
<name>
<surname>Long</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>RIPK2-mediated autophagy and negatively regulated ROS-NLRP3 inflammasome signaling in GMCs stimulated with high glucose</article-title>. <source>Mediators Inflamm</source> (<year>2019</year>) <volume>2019</volume>:<elocation-id>6207563</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/6207563</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy</article-title>. <source>FASEB J</source> (<year>2019</year>) <volume>33</volume>(<issue>3</issue>):<page-range>4571&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1096/fj.201801749RRR</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>MicroRNA-10 negatively regulates inflammation in diabetic kidney <italic>via</italic> targeting activation of the NLRP3 inflammasome</article-title>. <source>Mol Ther</source> (<year>2021</year>) <volume>29</volume>(<issue>7</issue>):<page-range>2308&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ymthe.2021.03.012</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
</person-group>. <source>The mechanism of miR-29a targeting regulation NLRP3 on glomerular podocyte pyroptosis under high glucose condition and analysis of the influencing factors of death in maintenance hemodialysis patients</source>. <publisher-loc>Kunming, Yunnan, China</publisher-loc>: <publisher-name>Kunming Medical University</publisher-name> (<year>2021</year>).</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gan</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of miR&#x2212;520c&#x2212;3p on pyroptosis of proximal tubular epithelial cells in diabetic kidney disease and its mechanism</article-title>. <source>Chin J Diabetes Mellitus</source> (<year>2022</year>) <volume>14</volume>(<issue>6</issue>):<fpage>592</fpage>&#x2013;<lpage>602</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3760/cma.j.cn115791-20210923-00513</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lian</surname> <given-names>W</given-names>
</name>
<name>
<surname>Han</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy</article-title>. <source>Exp Cell Res</source> (<year>2017</year>) <volume>350</volume>(<issue>2</issue>):<page-range>327&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yexcr.2016.12.006</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>He</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Atorvastatin regulates MALAT1/miR-200c/NRF2 activity to protect against podocyte pyroptosis induced by high glucose</article-title>. <source>Diabetes Metab Syndr Obes</source> (<year>2021</year>) <volume>14</volume>:<page-range>1631&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/DMSO.S298950</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhuo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>GX</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>XZ</given-names>
</name>
</person-group>. <article-title>LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3</article-title>. <source>Kaohsiung J Med Sci</source> (<year>2020</year>) <volume>36</volume>(<issue>9</issue>):<page-range>682&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/kjm2.12226</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhan</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>WW</given-names>
</name>
</person-group>. <article-title>Long non-coding RNA NEAT1 regulates pyroptosis in diabetic nephropathy <italic>via</italic> mediating the miR-34c/NLRP3 axis</article-title>. <source>Kidney Blood Press Res</source> (<year>2020</year>) <volume>45</volume>(<issue>4</issue>):<fpage>589</fpage>&#x2013;<lpage>602</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000508372</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Lateef</surname> <given-names>AEA</given-names>
</name>
<name>
<surname>El-Shemi</surname> <given-names>AGA</given-names>
</name>
<name>
<surname>Alhammady</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>LncRNA NEAT2 modulates pyroptosis of renal tubular cells induced by high glucose in diabetic nephropathy (DN) by <italic>via</italic> miR-206 regulation</article-title>. <source>Biochem Genet</source> (<year>2022</year>) <volume>60</volume>(<issue>5</issue>):<page-range>1733&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10528-021-10164-6</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Song</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>XH</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>PD</given-names>
</name>
<etal/>
</person-group>. <article-title>Long noncoding RNA X-inactive specific transcript regulates NLR family pyrin domain containing 3/caspase-1-mediated pyroptosis in diabetic nephropathy</article-title>. <source>World J Diabetes</source> (<year>2022</year>) <volume>13</volume>(<issue>4</issue>):<page-range>358&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4239/wjd.v13.i4.358</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Silencing of KCNQ1OT1 decreases oxidative stress and pyroptosis of renal tubular epithelial cells</article-title>. <source>Diabetes Metab Syndr Obes</source> (<year>2020</year>) <volume>13</volume>:<page-range>365&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/DMSO.S225791</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>lncRNA GAS5/miR-452-5p reduces oxidative stress and pyroptosis of high-Glucose-Stimulated renal tubular cells</article-title>. <source>Diabetes Metab Syndr Obes</source> (<year>2019</year>) <volume>12</volume>:<page-range>2609&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/DMSO.S228654</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Long noncoding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating NLRP3</article-title>. <source>Am J Physiol Cell Physiol</source> (<year>2021</year>) <volume>320</volume>(<issue>3</issue>):<page-range>C355&#x2013;C64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.00403.2020</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis <italic>via</italic> miR-497/thioredoxin-interacting protein axis in diabetic nephropathy</article-title>. <source>Life Sci</source> (<year>2021</year>) <volume>264</volume>:<elocation-id>118728</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2020.118728</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>LY</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>HD</given-names>
</name>
<etal/>
</person-group>. <article-title>LincRNA-Gm4419 knockdown ameliorates NF-kappaB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy</article-title>. <source>Cell Death Dis</source> (<year>2017</year>) <volume>8</volume>(<issue>2</issue>):<elocation-id>e2583</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cddis.2016.451</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Circ_0004951 promotes pyroptosis of renal tubular cells <italic>via</italic> the NLRP3 inflammasome in diabetic kidney disease</article-title>. <source>Front Med (Lausanne)</source> (<year>2022</year>) <volume>9</volume>:<elocation-id>828240</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2022.828240</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-6 receptor blockade ameliorates diabetic nephropathy <italic>via</italic> inhibiting inflammasome in mice</article-title>. <source>Metabolism</source> (<year>2018</year>) <volume>83</volume>:<fpage>18</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.metabol.2018.01.002</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Luan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bian</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation</article-title>. <source>Cell Death Dis</source> (<year>2017</year>) <volume>8</volume>(<issue>7</issue>):<fpage>e2937</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/cddis.2017.292</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fei</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Interleukin 37 (IL-37) reduces high glucose-induced inflammation, oxidative stress, and apoptosis of podocytes by inhibiting the STAT3-cyclophilin a (CypA) signaling pathway</article-title>. <source>Med Sci Monit</source> (<year>2020</year>) <volume>26</volume>:<fpage>e922979</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.12659/MSM.922979</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>YG</given-names>
</name>
</person-group>. <article-title>Bruton&#x2019;s tyrosine kinase regulates macrophage&#x2212;induced inflammation in the diabetic kidney <italic>via</italic> NLRP3 inflammasome activation</article-title>. <source>Int J Mol Med</source> (<year>2021</year>) <volume>48</volume>(<issue>3</issue>):<fpage>177</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijmm.2021.5010</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purvis</surname> <given-names>GSD</given-names>
</name>
<name>
<surname>Collino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aranda-Tavio</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chiazza</surname> <given-names>F</given-names>
</name>
<name>
<surname>O&#x2019;Riordan</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Zeboudj</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of bruton&#x2019;s TK regulates macrophage NF-kappaB and NLRP3 inflammasome activation in metabolic inflammation</article-title>. <source>Br J Pharmacol</source> (<year>2020</year>) <volume>177</volume>(<issue>19</issue>):<page-range>4416&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/bph.15182</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Inhibition of the glycogen synthase kinase 3beta-hypoxia-inducible factor 1alpha pathway alleviates NLRP3-mediated pyroptosis induced by high glucose in renal tubular epithelial cells</article-title>. <source>Exp Physiol</source> (<year>2022</year>) <volume>107</volume>(<issue>12</issue>):<page-range>1493&#x2013;506</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/EP090685</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Kan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of HDAC6 with CAY10603 ameliorates diabetic kidney disease by suppressing NLRP3 inflammasome</article-title>. <source>Front Pharmacol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>938391</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.938391</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy</article-title>. <source>Sci Rep</source> (<year>2020</year>) <volume>10</volume>(<issue>1</issue>):<fpage>10458</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-67054-x</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>X</given-names>
</name>
<name>
<surname>Men</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Spleen tyrosine kinase promotes NLR family pyrin domain containing 3 inflammasome&#x2212;mediated IL&#x2212;1&#x3b2; secretion <italic>via</italic> c&#x2212;Jun n&#x2212;terminal kinase activation and cell apoptosis during diabetic nephropathy</article-title>. <source>Mol Med Rep</source> (<year>2018</year>) <volume>18</volume>(<issue>2</issue>):<page-range>1995&#x2013;2008</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2018.9164</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collino</surname> <given-names>M</given-names>
</name>
<name>
<surname>Benetti</surname> <given-names>E</given-names>
</name>
<name>
<surname>Rogazzo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mastrocola</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yaqoob</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Aragno</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-delta agonism correlates with impaired NLRP3 inflammasome activation</article-title>. <source>Biochem Pharmacol</source> (<year>2013</year>) <volume>85</volume>(<issue>2</issue>):<page-range>257&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bcp.2012.10.014</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ying</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy</article-title>. <source>Inflammation Res</source> (<year>2022</year>) <volume>71</volume>(<issue>2</issue>):<fpage>191</fpage>&#x2013;<lpage>204</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00011-021-01532-4</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2022</year>) <volume>594</volume>:<page-range>131&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2021.12.068</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy</article-title>. <source>Cell Mol Biol Lett</source> (<year>2022</year>) <volume>27</volume>(<issue>1</issue>):<fpage>51</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s11658-022-00350-8</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Scheidereit</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The IkappaB kinase complex in NF-kappaB regulation and beyond</article-title>. <source>EMBO Rep</source> (<year>2014</year>) <volume>15</volume>(<issue>1</issue>):<fpage>46</fpage>&#x2013;<lpage>61</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/embr.201337983</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Song</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of genipin-1-&#x3b2;-d-gentiobioside on diabetic nephropathy in mice by activating AMP-activated protein kinase/silencing information regulator-related enzyme 1/nuclear factor-&#x3ba;B pathway</article-title>. <source>J Pharm Pharmacol</source> (<year>2021</year>) <volume>73</volume>(<issue>9</issue>):<page-range>1201&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jpp/rgab041</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>TXNIP: a double-edged sword in disease and therapeutic outlook</article-title>. <source>Oxid Med Cell Longev</source> (<year>2022</year>) <volume>2022</volume>:<elocation-id>7805115</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/7805115</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ludwig</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Kotanides</surname> <given-names>H</given-names>
</name>
<name>
<surname>Le</surname> <given-names>T</given-names>
</name>
<name>
<surname>Chavkin</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bohlen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Witte</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Cloning, genetic characterization, and chromosomal mapping of the mouse VDUP1 gene</article-title>. <source>Gene</source> (<year>2001</year>) <volume>269</volume>(<issue>1-2</issue>):<page-range>103&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0378-1119(01)00455-3</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>R</given-names>
</name>
<name>
<surname>Tardivel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Thorens</surname> <given-names>B</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>I</given-names>
</name>
<name>
<surname>Tschopp</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Thioredoxin-interacting protein links oxidative stress to inflammasome activation</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>(<issue>2</issue>):<page-range>136&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1831</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonelli</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chio</surname> <given-names>IIC</given-names>
</name>
<name>
<surname>Tuveson</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>Transcriptional regulation by Nrf2</article-title>. <source>Antioxid Redox Signal</source> (<year>2018</year>) <volume>29</volume>(<issue>17</issue>):<page-range>1727&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2017.7342</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva-Islas</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Maldonado</surname> <given-names>PD</given-names>
</name>
</person-group>. <article-title>Canonical and non-canonical mechanisms of Nrf2 activation</article-title>. <source>Pharmacol Res</source> (<year>2018</year>) <volume>134</volume>:<page-range>92&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2018.06.013</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hombach</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kretz</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Non-coding RNAs: classification, biology and functioning</article-title>. <source>Adv Exp Med Biol</source> (<year>2016</year>) <volume>937</volume>:<fpage>3</fpage>&#x2013;<lpage>17</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-319-42059-2_1</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kopp</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mendell</surname> <given-names>JT</given-names>
</name>
</person-group>. <article-title>Functional classification and experimental dissection of long noncoding RNAs</article-title>. <source>Cell</source> (<year>2018</year>) <volume>172</volume>(<issue>3</issue>):<fpage>393</fpage>&#x2013;<lpage>407</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2018.01.011</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilusz</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Sunwoo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Spector</surname> <given-names>DL</given-names>
</name>
</person-group>. <article-title>Long noncoding RNAs: functional surprises from the RNA world</article-title>. <source>Genes Dev</source> (<year>2009</year>) <volume>23</volume>(<issue>13</issue>):<page-range>1494&#x2013;504</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/gad.1800909</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname> <given-names>ANR</given-names>
</name>
<name>
<surname>Bittner</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Dang</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Radsak</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Brunner</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Bruton&#x2019;s tyrosine kinase: an emerging key player in innate immunity</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<elocation-id>1454</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.01454</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woodgett</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Cohen</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Multisite phosphorylation of glycogen synthase. molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5)</article-title>. <source>Biochim Biophys Acta</source> (<year>1984</year>) <volume>788</volume>(<issue>3</issue>):<page-range>339&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0167-4838(84)90047-5</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mennerich</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dimova</surname> <given-names>EY</given-names>
</name>
<name>
<surname>Kietzmann</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Direct phosphorylation events involved in HIF-alpha regulation: the role of GSK-3beta</article-title>. <source>Hypoxia (Auckl)</source> (<year>2014</year>) <volume>2</volume>:<fpage>35</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/HP.S60703</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyake</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Keusch</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Saito</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hess</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Structural insights into HDAC6 tubulin deacetylation and its selective inhibition</article-title>. <source>Nat Chem Biol</source> (<year>2016</year>) <volume>12</volume>(<issue>9</issue>):<page-range>748&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nchembio.2140</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wagner</surname> <given-names>KD</given-names>
</name>
</person-group>. <article-title>The role of PPARs in disease</article-title>. <source>Cells</source> (<year>2020</year>) <volume>9</volume>(<issue>11</issue>):<elocation-id>2367</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells9112367</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wada</surname> <given-names>J</given-names>
</name>
<name>
<surname>Makino</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Innate immunity in diabetes and diabetic nephropathy</article-title>. <source>Nat Rev Nephrol</source> (<year>2016</year>) <volume>12</volume>(<issue>1</issue>):<fpage>13</fpage>&#x2013;<lpage>26</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrneph.2015.175</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Jun</surname> <given-names>HS</given-names>
</name>
</person-group>. <article-title>Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy <italic>via</italic> Rac1/MAPK/KLF5 signaling</article-title>. <source>Exp Mol Med</source> (<year>2019</year>) <volume>51</volume>(<issue>2</issue>):<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s12276-019-0217-3</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Calabrese</surname> <given-names>MF</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Waddell</surname> <given-names>MB</given-names>
</name>
<name>
<surname>Nourse</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hammel</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases</article-title>. <source>Mol Cell</source> (<year>2009</year>) <volume>36</volume>(<issue>1</issue>):<fpage>39</fpage>&#x2013;<lpage>50</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2009.09.022</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guillamot</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ouazia</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dolgalev</surname> <given-names>I</given-names>
</name>
<name>
<surname>Yeung</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Kourtis</surname> <given-names>N</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation</article-title>. <source>Nat Immunol</source> (<year>2019</year>) <volume>20</volume>(<issue>9</issue>):<page-range>1196&#x2013;207</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-019-0454-6</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>G</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 inflammasome</article-title>. <source>BMC Complementary Altern Med</source> (<year>2018</year>) <volume>18</volume>(<issue>1</issue>):<fpage>192</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12906-018-2257-y</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>QY</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>LD</given-names>
</name>
</person-group>. <article-title>Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation</article-title>. <source>PloS One</source> (<year>2012</year>) <volume>7</volume>(<issue>6</issue>):<elocation-id>e38285</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0038285</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zai</surname> <given-names>W</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome</article-title>. <source>Phytomedicine</source> (<year>2018</year>) <volume>41</volume>:<fpage>45</fpage>&#x2013;<lpage>53</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2018.01.026</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Fisetin attenuates diabetic nephropathy-induced podocyte injury by inhibiting NLRP3 inflammasome</article-title>. <source>Front Pharmacol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>783706</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.783706</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ge</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lou</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation</article-title>. <source>Food Funct</source> (<year>2019</year>) <volume>10</volume>(<issue>5</issue>):<page-range>2970&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c8fo01653d</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-&#x3ba;B and NLRP3 inflammasome pathways</article-title>. <source>Biomed Pharmacother</source> (<year>2018</year>) <volume>106</volume>:<page-range>976&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2018.07.045</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alzahrani</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zaitone</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Said</surname> <given-names>E</given-names>
</name>
<name>
<surname>El-Sherbiny</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ajwah</surname> <given-names>S</given-names>
</name>
<name>
<surname>Alsharif</surname> <given-names>SY</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effect of isoliquiritigenin on experimental diabetic nephropathy in rats: impact on sirt-1/NFkappaB balance and NLRP3 expression</article-title>. <source>Int Immunopharmacol</source> (<year>2020</year>) <volume>87</volume>:<elocation-id>106813</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2020.106813</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yosri</surname> <given-names>H</given-names>
</name>
<name>
<surname>El-Kashef</surname> <given-names>DH</given-names>
</name>
<name>
<surname>El-Sherbiny</surname> <given-names>M</given-names>
</name>
<name>
<surname>Said</surname> <given-names>E</given-names>
</name>
<name>
<surname>Salem</surname> <given-names>HA</given-names>
</name>
</person-group>. <article-title>Calycosin modulates NLRP3 and TXNIP-mediated pyroptotic signaling and attenuates diabetic nephropathy progression in diabetic rats; an insight</article-title>. <source>BioMed Pharmacother</source> (<year>2022</year>) <volume>155</volume>:<elocation-id>113758</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.113758</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Luteolin attenuates high glucose-induced podocyte injury <italic>via</italic> suppressing NLRP3 inflammasome pathway</article-title>. <source>Life Sci</source> (<year>2019</year>) <volume>225</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2019.03.073</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Du</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Complanatoside a targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy</article-title>. <source>Phytomedicine</source> (<year>2022</year>) <volume>104</volume>:<elocation-id>154310</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2022.154310</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>The protective effect of kaempferol on renal function and tissue of diabetic nephropathy rats induced by high glucose</article-title>. <source>Immunol J</source> (<year>2018</year>) <volume>34</volume>(<issue>12</issue>):<page-range>1041&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13431/j.cnki.immunol.j.20180162</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Protective effect of scarithamine on diabetic nephropathy</article-title>. <source>Chin J Gerontology</source> (<year>2018</year>) <volume>38</volume>(<issue>6</issue>):<page-range>1433&#x2013;5</page-range>.</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yue</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Ginsenoside Rg1 alleviates podocyte injury induced by hyperlipidemia <italic>via</italic> targeting the mTOR/NF-kappaB/NLRP3 axis</article-title>. <source>Evid Based Complement Alternat Med</source> (<year>2020</year>) <volume>2020</volume>:<elocation-id>2735714</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2020/2735714</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Protective effect of ginsenoside Rg5 against kidney injury <italic>via</italic> inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet/streptozotocin-induced diabetic mice</article-title>. <source>Pharmacol Res</source> (<year>2020</year>) <volume>155</volume>:<elocation-id>104746</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104746</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>L</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-&#x3ba;B/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice</article-title>. <source>Int Immunopharmacol</source> (<year>2018</year>) <volume>63</volume>:<page-range>227&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2018.07.027</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>ZZ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>T</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>TT</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>TF</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YW</given-names>
</name>
</person-group>. <article-title>Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: <italic>In vivo</italic> and <italic>in vitro</italic> study</article-title>. <source>Phytomedicine</source> (<year>2020</year>) <volume>78</volume>:<elocation-id>153314</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2020.153314</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>YW</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats</article-title>. <source>Phytother Res</source> (<year>2018</year>) <volume>32</volume>(<issue>8</issue>):<page-range>1574&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ptr.6088</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>B</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome&#x2212;mediated inflammation</article-title>. <source>Int J Mol Med</source> (<year>2021</year>) <volume>48</volume>(<issue>2</issue>):<fpage>164</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijmm.2021.4996</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Inhibitory effect and mechanism of astragaloside IV on NLRP3 inflammasome activation pathway in mesangial cells of diabetic nephropathy based on the autophagy pathway</article-title>. <source>Guiding J Traditional Chin Med Pharmacol</source> (<year>2021</year>) <volume>27</volume>(<issue>9</issue>):<page-range>41&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13862/j.cnki.cn43-1446/r.2021.09.011</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Salidroside alleviates high glucose-induced oxidative stress and extracellular matrix accumulation in rat glomerular mesangial cells by the TXNIP-NLRP3 inflammasome pathway</article-title>. <source>Chem Biol Interact</source> (<year>2017</year>) <volume>278</volume>:<fpage>48</fpage>&#x2013;<lpage>53</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbi.2017.10.012</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gui</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Study on renal protective effect of notoginsenoside fc on db/db mice</article-title>. <source>Chin Arch Tranditional Chin Med</source> (<year>2017</year>) <volume>35</volume>(<issue>3</issue>):<page-range>609&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13193/j.issn.1673-7717.2017.03.026</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>G</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Tetrahydroxy stilbene glucoside alleviates high glucose-induced MPC5 podocytes injury through suppression of NLRP3 inflammasome</article-title>. <source>Am J Med Sci</source> (<year>2018</year>) <volume>355</volume>(<issue>6</issue>):<page-range>588&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.amjms.2018.03.005</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Gastrodin inhibits high glucose-induced inflammation, oxidative stress and apoptosis in podocytes by activating the AMPK/Nrf2 signaling pathway</article-title>. <source>Exp Ther Med</source> (<year>2022</year>) <volume>23</volume>(<issue>2</issue>):<fpage>168</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/etm.2021.11091</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Mehmood</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Epigallocatechin-3-gallate ameliorates renal endoplasmic reticulum stress-mediated inflammation in type 2 diabetic rats</article-title>. <source>Exp Biol Med (Maywood)</source> (<year>2022</year>) <volume>247</volume>(<issue>16</issue>):<page-range>1410&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/15353702221106479</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>YD</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>HX</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Leng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Thioredoxin-interacting protein mediates NLRP3 inflammasome activation involved in the susceptibility to ischemic acute kidney injury in diabetes</article-title>. <source>Oxid Med Cell Longev</source> (<year>2016</year>) <volume>2016</volume>:<elocation-id>2386068</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/2386068</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Yao</surname> <given-names>C</given-names>
</name>
</person-group>. <source>Piceatannol attenuates high glucose-induced podocyte injury via Nrf2-mediated inhibition of NLRP3 inflammasome</source>. <publisher-loc>Zhengzhou, Henan, China</publisher-loc>: <publisher-name>Zhengzhou University</publisher-name> (<year>2018</year>).</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling</article-title>. <source>BioMed Res Int</source> (<year>2017</year>) <volume>2017</volume>:<elocation-id>1516985</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/1516985</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Punicalagin protects diabetic nephropathy by inhibiting pyroptosis based on TXNIP/NLRP3 pathway</article-title>. <source>Nutrients</source> (<year>2020</year>) <volume>12</volume>(<issue>5</issue>):<fpage>1516</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12051516</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Shan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Mu</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Purple sweet potato color attenuates kidney damage by blocking VEGFR2/ROS/NLRP3 signaling in high-fat diet-treated mice</article-title>. <source>Oxid Med Cell Longev</source> (<year>2019</year>) <volume>2019</volume>:<elocation-id>5189819</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/5189819</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Effects of grape seed proanthocyanidins on renal ischemia-reperfusion injury in diabetic rats</article-title>. <source>Chin J Clin Pharmacol</source> (<year>2020</year>) <volume>36</volume>(<issue>14</issue>):<page-range>2036&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13699/j.cnki.1001-6821.2020.14.034</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YX</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>LR</given-names>
</name>
<etal/>
</person-group>. <article-title>Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation</article-title>. <source>Acta Pharmacol Sin</source> (<year>2021</year>) <volume>42</volume>(<issue>6</issue>):<page-range>975&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41401-020-00527-x</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-kappaB pathway</article-title>. <source>Eur J Pharmacol</source> (<year>2020</year>) <volume>886</volume>:<elocation-id>173449</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2020.173449</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname> <given-names>J</given-names>
</name>
<name>
<surname>He</surname> <given-names>L</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Pei</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural swietenine attenuates diabetic nephropathy by regulating the NF-kappaB/NLRP3/Caspase-1 signaling pathways: <italic>In vivo</italic> and <italic>in vitro</italic> study</article-title>. <source>Environ Toxicol</source> (<year>2022</year>) <volume>37</volume>(<issue>12</issue>):<page-range>2977&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/tox.23653</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-&#x3ba;B/NLRP3 inflammasome pathway</article-title>. <source>Chemico-Biological Interactions</source> (<year>2018</year>) <volume>293</volume>:<page-range>11&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbi.2018.07.011</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Study on the inhibitive effect of catalpol on diabetic nephropathy</article-title>. <source>Life Sci</source> (<year>2020</year>) <volume>257</volume>:<elocation-id>118120</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2020.118120</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of andrographolide on renal tubulointersticial injury and fibrosis</article-title>. <source>Evidence its Mech action Phytomedicine</source> (<year>2021</year>) <volume>91</volume>:<elocation-id>153650</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2021.153650</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose</article-title>. <source>J Chin Materia Med</source> (<year>2019</year>) <volume>44</volume>(<issue>24</issue>):<page-range>5457&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.19540/j.cnki.cjcmm.20191114.401</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome</article-title>. <source>Ren Fail</source> (<year>2022</year>) <volume>44</volume>(<issue>1</issue>):<page-range>923&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/0886022X.2022.2079525</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samra</surname> <given-names>YA</given-names>
</name>
<name>
<surname>Said</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Elsherbiny</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Liou</surname> <given-names>GI</given-names>
</name>
<name>
<surname>El-Shishtawy</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Eissa</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>Cepharanthine and piperine ameliorate diabetic nephropathy in rats: role of NF-kappaB and NLRP3 inflammasome</article-title>. <source>Life Sci</source> (<year>2016</year>) <volume>157</volume>:<page-range>187&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2016.06.002</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation</article-title>. <source>Drug Dev Res</source> (<year>2022</year>) <volume>83</volume>(<issue>7</issue>):<page-range>1697&#x2013;706</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ddr.21988</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>X</given-names>
</name>
</person-group>. <source>Effects and mechanisms of rutaecarpine on podocyte injury on diabetic kidney disease</source>. <publisher-loc>Hefei, Anhui, China</publisher-loc>: <publisher-name>Anhui Medical University</publisher-name> (<year>2022</year>).</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Sui</surname> <given-names>B</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Schisandrin a from schisandra chinensis attenuates ferroptosis and NLRP3 inflammasome-mediated pyroptosis in diabetic nephropathy through mitochondrial damage by AdipoR1 ubiquitination</article-title>. <source>Oxid Med Cell Longev</source> (<year>2022</year>) <volume>2022</volume>:<elocation-id>5411462</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/5411462</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>R</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>G</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Ferulic acid ameliorates renal injury <italic>via</italic> improving autophagy to inhibit inflammation in diabetic nephropathy mice</article-title>. <source>BioMed Pharmacother</source> (<year>2022</year>) <volume>153</volume>:<elocation-id>113424</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.113424</pub-id>
</citation>
</ref>
<ref id="B124">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Han</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>YJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Sauchinone protects renal mesangial cell dysfunction against angiotensin II by improving renal fibrosis and inflammation</article-title>. <source>Int J Mol Sci</source> (<year>2020</year>) <volume>21</volume>(<issue>19</issue>):<fpage>7003</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms21197003</pub-id>
</citation>
</ref>
<ref id="B125">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats <italic>via</italic> NLRP3 inflammasomes</article-title>. <source>Life Sci</source> (<year>2021</year>) <volume>278</volume>:<elocation-id>119542</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2021.119542</pub-id>
</citation>
</ref>
<ref id="B126">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhai</surname> <given-names>B</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells</article-title>. <source>BioMed Pharmacother</source> (<year>2022</year>) <volume>150</volume>:<elocation-id>112998</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.112998</pub-id>
</citation>
</ref>
<ref id="B127">
<label>127</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>W</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Apocynin inhibited NLRP3/XIAP signalling to alleviate renal fibrotic injury in rat diabetic nephropathy</article-title>. <source>Biomed Pharmacother</source> (<year>2018</year>) <volume>106</volume>:<page-range>1325&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2018.07.036</pub-id>
</citation>
</ref>
<ref id="B128">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Effect of diallyl trisulfide on pyroptosis in renal tissue of diabetic nephropathy rats</article-title>. <source>J Guangzhou Univ Traditional Chin Med</source> (<year>2022</year>) <volume>39</volume>(<issue>7</issue>):<page-range>1643&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13359/j.cnki.gzxbtcm.2022.07.031</pub-id>
</citation>
</ref>
<ref id="B129">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Pinto</surname> <given-names>D</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>AMS</given-names>
</name>
</person-group>. <article-title>Plant flavonoids: chemical characteristics and biological activity</article-title>. <source>Molecules</source> (<year>2021</year>) <volume>26</volume>(<issue>17</issue>):<elocation-id>5377</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26175377</pub-id>
</citation>
</ref>
<ref id="B130">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadowska-Bartosz</surname> <given-names>I</given-names>
</name>
<name>
<surname>Galiniak</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bartosz</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Polyphenols protect against protein glycoxidation</article-title>. <source>Free Radic Biol Med</source> (<year>2014</year>) <volume>75 Suppl 1</volume>:<fpage>S47</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.10.810</pub-id>
</citation>
</ref>
<ref id="B131">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhanya</surname> <given-names>R</given-names>
</name>
<name>
<surname>Arun</surname> <given-names>KB</given-names>
</name>
<name>
<surname>Nisha</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Syama</surname> <given-names>HP</given-names>
</name>
<name>
<surname>Nisha</surname> <given-names>P</given-names>
</name>
<name>
<surname>Santhosh Kumar</surname> <given-names>TR</given-names>
</name>
<etal/>
</person-group>. <article-title>Preconditioning L6 muscle cells with naringin ameliorates oxidative stress and increases glucose uptake</article-title>. <source>PloS One</source> (<year>2015</year>) <volume>10</volume>(<issue>7</issue>):<elocation-id>e0132429</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0132429</pub-id>
</citation>
</ref>
<ref id="B132">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kandhare</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Ghosh</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bodhankar</surname> <given-names>SL</given-names>
</name>
</person-group>. <article-title>Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats</article-title>. <source>Chem Biol Interact</source> (<year>2014</year>) <volume>219</volume>:<page-range>101&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbi.2014.05.012</pub-id>
</citation>
</ref>
<ref id="B133">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hosseini</surname> <given-names>A</given-names>
</name>
<name>
<surname>Razavi</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Banach</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hosseinzadeh</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Quercetin and metabolic syndrome: a review</article-title>. <source>Phytother Res</source> (<year>2021</year>) <volume>35</volume>(<issue>10</issue>):<page-range>5352&#x2013;64</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ptr.7144</pub-id>
</citation>
</ref>
<ref id="B134">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Li</surname> <given-names>HF</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>FC</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>MY</given-names>
</name>
<etal/>
</person-group>. <article-title>Detection of 191 taxifolin metabolites and their distribution in rats using HPLC-ESI-IT-TOF-MS(n)</article-title>. <source>Molecules</source> (<year>2016</year>) <volume>21</volume>(<issue>9</issue>):<fpage>1209</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules21091209</pub-id>
</citation>
</ref>
<ref id="B135">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ebrahimpour</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zakeri</surname> <given-names>M</given-names>
</name>
<name>
<surname>Esmaeili</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Crosstalk between obesity, diabetes, and alzheimer&#x2019;s disease: introducing quercetin as an effective triple herbal medicine</article-title>. <source>Ageing Res Rev</source> (<year>2020</year>) <volume>62</volume>:<elocation-id>101095</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.arr.2020.101095</pub-id>
</citation>
</ref>
<ref id="B136">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khursheed</surname> <given-names>R</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Wadhwa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gulati</surname> <given-names>M</given-names>
</name>
<name>
<surname>Awasthi</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Enhancing the potential preclinical and clinical benefits of quercetin through novel drug delivery systems</article-title>. <source>Drug Discov Today</source> (<year>2020</year>) <volume>25</volume>(<issue>1</issue>):<page-range>209&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.drudis.2019.11.001</pub-id>
</citation>
</ref>
<ref id="B137">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>RV</given-names>
</name>
<name>
<surname>Mistry</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Shinde</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Syed</surname> <given-names>R</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>HS</given-names>
</name>
</person-group>. <article-title>Therapeutic potential of quercetin as a cardiovascular agent</article-title>. <source>Eur J Med Chem</source> (<year>2018</year>) <volume>155</volume>:<fpage>889</fpage>&#x2013;<lpage>904</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejmech.2018.06.053</pub-id>
</citation>
</ref>
<ref id="B138">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Long</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Quercetin: its main pharmacological activity and potential application in clinical medicine</article-title>. <source>Oxid Med Cell Longev</source> (<year>2020</year>) <volume>2020</volume>:<elocation-id>8825387</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2020/8825387</pub-id>
</citation>
</ref>
<ref id="B139">
<label>139</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weidmann</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>Dihydroquercetin: more than just an impurity</article-title>? <source>Eur J Pharmacol</source> (<year>2012</year>) <volume>684</volume>(<issue>1-3</issue>):<fpage>19</fpage>&#x2013;<lpage>26</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2012.03.035</pub-id>
</citation>
</ref>
<ref id="B140">
<label>140</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Effective dose/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: a systematic review and meta-analysis of rodent data</article-title>. <source>Phytomedicine</source> (<year>2022</year>) <volume>105</volume>:<elocation-id>154348</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2022.154348</pub-id>
</citation>
</ref>
<ref id="B141">
<label>141</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rengarajan</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yaacob</surname> <given-names>NS</given-names>
</name>
</person-group>. <article-title>The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways</article-title>. <source>Eur J Pharmacol</source> (<year>2016</year>) <volume>789</volume>:<fpage>8</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2016.07.001</pub-id>
</citation>
</ref>
<ref id="B142">
<label>142</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>B</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Fisetin inhibits cardiac hypertrophy by suppressing oxidative stress</article-title>. <source>J Nutr Biochem</source> (<year>2018</year>) <volume>62</volume>:<page-range>221&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jnutbio.2018.08.010</pub-id>
</citation>
</ref>
<ref id="B143">
<label>143</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Fisetin prevents acetaminophen-induced liver injury by promoting autophagy</article-title>. <source>Front Pharmacol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>162</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2020.00162</pub-id>
</citation>
</ref>
<ref id="B144">
<label>144</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asl</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Hosseinzadeh</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Review of pharmacological effects of glycyrrhiza sp. and its bioactive compounds</article-title>. <source>Phytother Res</source> (<year>2008</year>) <volume>22</volume>(<issue>6</issue>):<page-range>709&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ptr.2362</pub-id>
</citation>
</ref>
<ref id="B145">
<label>145</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>T</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Antimicrobial activity of licochalcone e against staphylococcus aureus and its impact on the production of staphylococcal alpha-toxin</article-title>. <source>J Microbiol Biotechnol</source> (<year>2012</year>) <volume>22</volume>(<issue>6</issue>):<page-range>800&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4014/jmb.1112.12020</pub-id>
</citation>
</ref>
<ref id="B146">
<label>146</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Ha</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>YS</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Anti-inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver</article-title>. <source>Molecules</source> (<year>2015</year>) <volume>20</volume>(<issue>7</issue>):<page-range>13041&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules200713041</pub-id>
</citation>
</ref>
<ref id="B147">
<label>147</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Ku</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>IJ</given-names>
</name>
<name>
<surname>Byun</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SC</given-names>
</name>
<etal/>
</person-group>. <article-title>Isoliquiritigenin in licorice functions as a hepatic protectant by induction of antioxidant genes through extracellular signal-regulated kinase-mediated NF-E2-related factor-2 signaling pathway</article-title>. <source>Eur J Nutr</source> (<year>2016</year>) <volume>55</volume>(<issue>8</issue>):<page-range>2431&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00394-015-1051-6</pub-id>
</citation>
</ref>
<ref id="B148">
<label>148</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Su</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>DD</given-names>
</name>
</person-group>. <article-title>Isoliquiritigenin inhibits ovarian cancer metastasis by reversing epithelial-to-Mesenchymal transition</article-title>. <source>Molecules</source> (<year>2019</year>) <volume>24</volume>(<issue>20</issue>):<fpage>3725</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules24203725</pub-id>
</citation>
</ref>
<ref id="B149">
<label>149</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Pharmacological effects of icariin</article-title>. <source>Adv Pharmacol</source> (<year>2020</year>) <volume>87</volume>:<fpage>179</fpage>&#x2013;<lpage>203</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/bs.apha.2019.10.004</pub-id>
</citation>
</ref>
<ref id="B150">
<label>150</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Du</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Calycosin&#x2212;7&#x2212;O&#x2212;beta&#x2212;D&#x2212;glucoside attenuates ischemia&#x2212;reperfusion injury <italic>in vivo via</italic> activation of the PI3K/Akt pathway</article-title>. <source>Mol Med Rep</source> (<year>2016</year>) <volume>13</volume>(<issue>1</issue>):<page-range>633&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2015.4611</pub-id>
</citation>
</ref>
<ref id="B151">
<label>151</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsherbiny</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Said</surname> <given-names>E</given-names>
</name>
<name>
<surname>Atef</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zaitone</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Renoprotective effect of calycosin in high fat diet-fed/STZ injected rats: effect on IL-33/ST2 signaling, oxidative stress and fibrosis suppression</article-title>. <source>Chem Biol Interact</source> (<year>2020</year>) <volume>315</volume>:<elocation-id>108897</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbi.2019.108897</pub-id>
</citation>
</ref>
<ref id="B152">
<label>152</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Luteolin, a natural flavonoid, inhibits methylglyoxal induced apoptosis <italic>via</italic> the mTOR/4E-BP1 signaling pathway</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>(<issue>1</issue>):<fpage>7877</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-08204-6</pub-id>
</citation>
</ref>
<ref id="B153">
<label>153</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>BR</given-names>
</name>
</person-group>. <article-title>Luteolin suppresses cisplatin-induced apoptosis in auditory cells: possible mediation through induction of heme oxygenase-1 expression</article-title>. <source>J Med Food</source> (<year>2008</year>) <volume>11</volume>(<issue>2</issue>):<page-range>230&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/jmf.2007.591</pub-id>
</citation>
</ref>
<ref id="B154">
<label>154</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aziz</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>JY</given-names>
</name>
</person-group>. <article-title>Anti-inflammatory effects of luteolin: a review of <italic>in vitro</italic>, <italic>in vivo</italic>, and in silico studies</article-title>. <source>J Ethnopharmacol</source> (<year>2018</year>) <volume>225</volume>:<page-range>342&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2018.05.019</pub-id>
</citation>
</ref>
<ref id="B155">
<label>155</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname> <given-names>YF</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>PC</given-names>
</name>
<name>
<surname>Sham</surname> <given-names>TT</given-names>
</name>
<name>
<surname>Lam</surname> <given-names>WS</given-names>
</name>
<name>
<surname>Mok</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>SW</given-names>
</name>
</person-group>. <article-title>Semen astragali complanati: an ethnopharmacological, phytochemical and pharmacological review</article-title>. <source>J Ethnopharmacol</source> (<year>2014</year>) <volume>155</volume>(<issue>1</issue>):<fpage>39</fpage>&#x2013;<lpage>53</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2014.06.013</pub-id>
</citation>
</ref>
<ref id="B156">
<label>156</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Salehi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Sharifi-Rad</surname> <given-names>J</given-names>
</name>
<name>
<surname>Aslam Gondal</surname> <given-names>T</given-names>
</name>
<name>
<surname>Saeed</surname> <given-names>F</given-names>
</name>
<name>
<surname>Imran</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Kaempferol: a key emphasis to its anticancer potential</article-title>. <source>Molecules</source> (<year>2019</year>) <volume>24</volume>(<issue>12</issue>):<fpage>2277</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules24122277</pub-id>
</citation>
</ref>
<ref id="B157">
<label>157</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devi</surname> <given-names>KP</given-names>
</name>
<name>
<surname>Malar</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Nabavi</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Sureda</surname> <given-names>A</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nabavi</surname> <given-names>SM</given-names>
</name>
<etal/>
</person-group>. <article-title>Kaempferol and inflammation: from chemistry to medicine</article-title>. <source>Pharmacol Res</source> (<year>2015</year>) <volume>99</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2015.05.002</pub-id>
</citation>
</ref>
<ref id="B158">
<label>158</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Carthamin yellow improves cerebral ischemia&#x2212;reperfusion injury by attenuating inflammation and ferroptosis in rats</article-title>. <source>Int J Mol Med</source> (<year>2021</year>) <volume>47</volume>(<issue>4</issue>):<fpage>52</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/ijmm.2021.4885</pub-id>
</citation>
</ref>
<ref id="B159">
<label>159</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chaudhuri</surname> <given-names>PK</given-names>
</name>
</person-group>. <article-title>Structural characteristics, bioavailability and cardioprotective potential of saponins</article-title>. <source>Integr Med Res</source> (<year>2018</year>) <volume>7</volume>(<issue>1</issue>):<fpage>33</fpage>&#x2013;<lpage>43</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.imr.2018.01.003</pub-id>
</citation>
</ref>
<ref id="B160">
<label>160</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>WZ</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>WY</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>M</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>Saponins in the genus panax l. (Araliaceae): a systematic review of their chemical diversity</article-title>. <source>Phytochemistry</source> (<year>2014</year>) <volume>106</volume>:<fpage>7</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phytochem.2014.07.012</pub-id>
</citation>
</ref>
<ref id="B161">
<label>161</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coon</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Ernst</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Panax ginseng: a systematic review of adverse effects and drug interactions</article-title>. <source>Drug Saf</source> (<year>2002</year>) <volume>25</volume>(<issue>5</issue>):<page-range>323&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2165/00002018-200225050-00003</pub-id>
</citation>
</ref>
<ref id="B162">
<label>162</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakata</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kikuchi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tode</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hirata</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kita</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ishii</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells</article-title>. <source>Jpn J Cancer Res</source> (<year>1998</year>) <volume>89</volume>(<issue>7</issue>):<page-range>733&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1349-7006.1998.tb03278.x</pub-id>
</citation>
</ref>
<ref id="B163">
<label>163</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>PH</given-names>
</name>
<name>
<surname>Lumsden</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Molecular mechanisms and clinical applications of ginseng root for cardiovascular disease</article-title>. <source>Med Sci Monit</source> (<year>2004</year>) <volume>10</volume>(<issue>8</issue>):<page-range>RA187&#x2013;92</page-range>.</citation>
</ref>
<ref id="B164">
<label>164</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Mehendale</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Quigg</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>CZ</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-diabetic effect of ginsenoside re in ob/ob mice</article-title>. <source>Biochim Biophys Acta</source> (<year>2005</year>) <volume>1740</volume>(<issue>3</issue>):<page-range>319&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbadis.2004.10.010</pub-id>
</citation>
</ref>
<ref id="B165">
<label>165</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Chun</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Cheong</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>YS</given-names>
</name>
<etal/>
</person-group>. <article-title>Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplification</article-title>. <source>Oncotarget</source> (<year>2016</year>) <volume>7</volume>(<issue>23</issue>):<page-range>35144&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/oncotarget.9059</pub-id>
</citation>
</ref>
<ref id="B166">
<label>166</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname> <given-names>LD</given-names>
</name>
<name>
<surname>He</surname> <given-names>T</given-names>
</name>
<name>
<surname>Du</surname> <given-names>TW</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>YG</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Ginsenoside&#x2212;Rg5 induces apoptosis and DNA damage in human cervical cancer cells</article-title>. <source>Mol Med Rep</source> (<year>2015</year>) <volume>11</volume>(<issue>2</issue>):<page-range>940&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2014.2821</pub-id>
</citation>
</ref>
<ref id="B167">
<label>167</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>XD</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Ouyang</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>A review of biotransformation and pharmacology of ginsenoside compound K</article-title>. <source>Fitoterapia</source> (<year>2015</year>) <volume>100</volume>:<page-range>208&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fitote.2014.11.019</pub-id>
</citation>
</ref>
<ref id="B168">
<label>168</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>B</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>CQ</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Steroidal glycosides from the rhizomes of anemarrhena asphodeloides and their antiplatelet aggregation activity</article-title>. <source>Planta Med</source> (<year>2012</year>) <volume>78</volume>(<issue>6</issue>):<page-range>611&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0031-1298223</pub-id>
</citation>
</ref>
<ref id="B169">
<label>169</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Ryu</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>YW</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>JH</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-inflammatory effect of anemarsaponin b isolated from the rhizomes of anemarrhena asphodeloides in LPS-induced RAW 264.7 macrophages is mediated by negative regulation of the nuclear factor-kappaB and p38 pathways</article-title>. <source>Food Chem Toxicol</source> (<year>2009</year>) <volume>47</volume>(<issue>7</issue>):<page-range>1610&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2009.04.009</pub-id>
</citation>
</ref>
<ref id="B170">
<label>170</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>DH</given-names>
</name>
</person-group>. <article-title>Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-kappaB and MAPK activation and restoring Th17/Treg cell balance</article-title>. <source>Int Immunopharmacol</source> (<year>2015</year>) <volume>25</volume>(<issue>2</issue>):<fpage>493</fpage>&#x2013;<lpage>503</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2015.02.016</pub-id>
</citation>
</ref>
<ref id="B171">
<label>171</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-inflammatory activities of compounds isolated from the rhizome of anemarrhena asphodeloides</article-title>. <source>Molecules</source> (<year>2018</year>) <volume>23</volume>(<issue>10</issue>):<fpage>2631</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules23102631</pub-id>
</citation>
</ref>
<ref id="B172">
<label>172</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Astragaloside IV alleviates myocardial damage induced by type 2 diabetes <italic>via</italic> improving energy metabolism</article-title>. <source>Mol Med Rep</source> (<year>2019</year>) <volume>20</volume>(<issue>5</issue>):<page-range>4612&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2019.10716</pub-id>
</citation>
</ref>
<ref id="B173">
<label>173</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Research review on the pharmacological effects of astragaloside IV</article-title>. <source>Fundam Clin Pharmacol</source> (<year>2017</year>) <volume>31</volume>(<issue>1</issue>):<fpage>17</fpage>&#x2013;<lpage>36</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/fcp.12232</pub-id>
</citation>
</ref>
<ref id="B174">
<label>174</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname> <given-names>GL</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>R</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>ZM</given-names>
</name>
</person-group>. <article-title>Salidroside ameliorates diabetic neuropathic pain in rats by inhibiting neuroinflammation</article-title>. <source>J Mol Neurosci</source> (<year>2017</year>) <volume>63</volume>(<issue>1</issue>):<fpage>9</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12031-017-0951-8</pub-id>
</citation>
</ref>
<ref id="B175">
<label>175</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Maimaitijiang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Salidroside inhibits high-glucose induced proliferation of vascular smooth muscle cells <italic>via</italic> inhibiting mitochondrial fission and oxidative stress</article-title>. <source>Exp Ther Med</source> (<year>2017</year>) <volume>14</volume>(<issue>1</issue>):<page-range>515&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/etm.2017.4541</pub-id>
</citation>
</ref>
<ref id="B176">
<label>176</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Lian</surname> <given-names>LH</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>YZ</given-names>
</name>
<name>
<surname>Nan</surname> <given-names>JX</given-names>
</name>
</person-group>. <article-title>Hepatoprotective effects of salidroside on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice</article-title>. <source>J Pharm Pharmacol</source> (<year>2009</year>) <volume>61</volume>(<issue>10</issue>):<page-range>1375&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1211/jpp/61.10.0015</pub-id>
</citation>
</ref>
<ref id="B177">
<label>177</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname> <given-names>D</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Salidroside, the main active compound of rhodiola plants, inhibits high glucose-induced mesangial cell proliferation</article-title>. <source>Planta Med</source> (<year>2009</year>) <volume>75</volume>(<issue>11</issue>):<page-range>1191&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1055/s-0029-1185717</pub-id>
</citation>
</ref>
<ref id="B178">
<label>178</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Pharmacokinetics, bioavailability, and metabolism of notoginsenoside fc in rats by liquid chromatography/electrospray ionization tandem mass spectrometry</article-title>. <source>J Pharm BioMed Anal</source> (<year>2015</year>) <volume>109</volume>:<page-range>150&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpba.2015.02.038</pub-id>
</citation>
</ref>
<ref id="B179">
<label>179</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Casado-Andres</surname> <given-names>M</given-names>
</name>
<name>
<surname>Goikoetxea-Usandizaga</surname> <given-names>N</given-names>
</name>
<name>
<surname>Serrano-Macia</surname> <given-names>M</given-names>
</name>
<name>
<surname>Martinez-Chantar</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>Nutraceutical properties of polyphenols against liver diseases</article-title>. <source>Nutrients</source> (<year>2020</year>) <volume>12</volume>(<issue>11</issue>):<fpage>3517</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12113517</pub-id>
</citation>
</ref>
<ref id="B180">
<label>180</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>T</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE(-/-) mice</article-title>. <source>J Ethnopharmacol</source> (<year>2020</year>) <volume>247</volume>:<elocation-id>112232</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2019.112232</pub-id>
</citation>
</ref>
<ref id="B181">
<label>181</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>CB</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>QL</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>YN</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>JG</given-names>
</name>
</person-group>. <article-title>Gastrodin derivatives from gastrodia elata</article-title>. <source>Nat Prod Bioprospect</source> (<year>2019</year>) <volume>9</volume>(<issue>6</issue>):<fpage>393</fpage>&#x2013;<lpage>404</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13659-019-00224-1</pub-id>
</citation>
</ref>
<ref id="B182">
<label>182</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>M</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>A review on central nervous system effects of gastrodin</article-title>. <source>Front Pharmacol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>24</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2018.00024</pub-id>
</citation>
</ref>
<ref id="B183">
<label>183</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertelli</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Das</surname> <given-names>DK</given-names>
</name>
</person-group>. <article-title>Grapes, wines, resveratrol, and heart health</article-title>. <source>J Cardiovasc Pharmacol</source> (<year>2009</year>) <volume>54</volume>(<issue>6</issue>):<page-range>468&#x2013;76</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/FJC.0b013e3181bfaff3</pub-id>
</citation>
</ref>
<ref id="B184">
<label>184</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitada</surname> <given-names>M</given-names>
</name>
<name>
<surname>Koya</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Renal protective effects of resveratrol</article-title>. <source>Oxid Med Cell Longev</source> (<year>2013</year>) <volume>2013</volume>:<elocation-id>568093</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2013/568093</pub-id>
</citation>
</ref>
<ref id="B185">
<label>185</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitada</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kume</surname> <given-names>S</given-names>
</name>
<name>
<surname>Imaizumi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Koya</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway</article-title>. <source>Diabetes</source> (<year>2011</year>) <volume>60</volume>(<issue>2</issue>):<page-range>634&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db10-0386</pub-id>
</citation>
</ref>
<ref id="B186">
<label>186</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piotrowska</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kucinska</surname> <given-names>M</given-names>
</name>
<name>
<surname>Murias</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Biological activity of piceatannol: leaving the shadow of resveratrol</article-title>. <source>Mutat Res</source> (<year>2012</year>) <volume>750</volume>(<issue>1</issue>):<fpage>60</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mrrev.2011.11.001</pub-id>
</citation>
</ref>
<ref id="B187">
<label>187</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banik</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ranaware</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Harsha</surname> <given-names>C</given-names>
</name>
<name>
<surname>Nitesh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Girisa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Deshpande</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Piceatannol: a natural stilbene for the prevention and treatment of cancer</article-title>. <source>Pharmacol Res</source> (<year>2020</year>) <volume>153</volume>:<elocation-id>104635</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2020.104635</pub-id>
</citation>
</ref>
<ref id="B188">
<label>188</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Autophagy activation by dietary piceatannol enhances the efficacy of immunogenic chemotherapy</article-title>. <source>Front Immunol</source> (<year>2022</year>) <volume>13</volume>:<elocation-id>968686</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.968686</pub-id>
</citation>
</ref>
<ref id="B189">
<label>189</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kershaw</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Elzey</surname> <given-names>BD</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>XX</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>KH</given-names>
</name>
</person-group>. <article-title>Piceatannol, a dietary polyphenol, alleviates adipose tissue loss in pre-clinical model of cancer-associated cachexia <italic>via</italic> lipolysis inhibition</article-title>. <source>Nutrients</source> (<year>2022</year>) <volume>14</volume>(<issue>11</issue>):<fpage>2306</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu14112306</pub-id>
</citation>
</ref>
<ref id="B190">
<label>190</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>SW</given-names>
</name>
</person-group>. <article-title>A review of the pharmacological effects of piceatannol on cardiovascular diseases</article-title>. <source>Phytother Res</source> (<year>2014</year>) <volume>28</volume>(<issue>11</issue>):<page-range>1581&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ptr.5185</pub-id>
</citation>
</ref>
<ref id="B191">
<label>191</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sil</surname> <given-names>PC</given-names>
</name>
</person-group>. <article-title>The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: a recent update</article-title>. <source>Food Chem Toxicol</source> (<year>2015</year>) <volume>83</volume>:<page-range>111&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2015.05.022</pub-id>
</citation>
</ref>
<ref id="B192">
<label>192</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suresh Babu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Srinivasan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats</article-title>. <source>Mol Cell Biochem</source> (<year>1998</year>) <volume>181</volume>(<issue>1-2</issue>):<fpage>87</fpage>&#x2013;<lpage>96</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1023/a:1006821828706</pub-id>
</citation>
</ref>
<ref id="B193">
<label>193</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kulkarni</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Chopra</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats</article-title>. <source>Clin Exp Pharmacol Physiol</source> (<year>2006</year>) <volume>33</volume>(<issue>10</issue>):<page-range>940&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1440-1681.2006.04468.x</pub-id>
</citation>
</ref>
<ref id="B194">
<label>194</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshida</surname> <given-names>T</given-names>
</name>
<name>
<surname>Amakura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yoshimura</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Structural features and biological properties of ellagitannins in some plant families of the order myrtales</article-title>. <source>Int J Mol Sci</source> (<year>2010</year>) <volume>11</volume>(<issue>1</issue>):<fpage>79</fpage>&#x2013;<lpage>106</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms11010079</pub-id>
</citation>
</ref>
<ref id="B195">
<label>195</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berdowska</surname> <given-names>I</given-names>
</name>
<name>
<surname>Matusiewicz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fecka</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Punicalagin in cancer prevention-via signaling pathways targeting</article-title>. <source>Nutrients</source> (<year>2021</year>) <volume>13</volume>(<issue>8</issue>):<fpage>2733</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu13082733</pub-id>
</citation>
</ref>
<ref id="B196">
<label>196</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Punicalagin prevents inflammation in LPS-induced RAW264.7 macrophages by inhibiting FoxO3a/Autophagy signaling pathway</article-title>. <source>Nutrients</source> (<year>2019</year>) <volume>11</volume>(<issue>11</issue>):<fpage>2794</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu11112794</pub-id>
</citation>
</ref>
<ref id="B197">
<label>197</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>K</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Punicalagin regulates signaling pathways in inflammation-associated chronic diseases</article-title>. <source>Antioxidants (Basel)</source> (<year>2021</year>) <volume>11</volume>(<issue>1</issue>):<fpage>29</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antiox11010029</pub-id>
</citation>
</ref>
<ref id="B198">
<label>198</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Purple sweet potato color ameliorates kidney damage <italic>via</italic> inhibiting oxidative stress mediated NLRP3 inflammasome activation in high fat diet mice</article-title>. <source>Food Chem Toxicol</source> (<year>2014</year>) <volume>69</volume>:<page-range>339&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2014.04.033</pub-id>
</citation>
</ref>
<ref id="B199">
<label>199</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Shan</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Purple sweet potato color attenuates oxidative stress and inflammatory response induced by d-galactose in mouse liver</article-title>. <source>Food Chem Toxicol</source> (<year>2009</year>) <volume>47</volume>(<issue>2</issue>):<fpage>496</fpage>&#x2013;<lpage>501</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.fct.2008.12.005</pub-id>
</citation>
</ref>
<ref id="B200">
<label>200</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Purple sweet potato color inhibits endothelial premature senescence by blocking the NLRP3 inflammasome</article-title>. <source>J Nutr Biochem</source> (<year>2015</year>) <volume>26</volume>(<issue>10</issue>):<page-range>1029&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jnutbio.2015.04.012</pub-id>
</citation>
</ref>
<ref id="B201">
<label>201</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagchi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bagchi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Stohs</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Das</surname> <given-names>DK</given-names>
</name>
<name>
<surname>Ray</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Kuszynski</surname> <given-names>CA</given-names>
</name>
<etal/>
</person-group>. <article-title>Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention</article-title>. <source>Toxicology</source> (<year>2000</year>) <volume>148</volume>(<issue>2-3</issue>):<page-range>187&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0300-483x(00)00210-9</pub-id>
</citation>
</ref>
<ref id="B202">
<label>202</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rozanska</surname> <given-names>D</given-names>
</name>
<name>
<surname>Regulska-Ilow</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>The significance of anthocyanins in the prevention and treatment of type 2 diabetes</article-title>. <source>Adv Clin Exp Med</source> (<year>2018</year>) <volume>27</volume>(<issue>1</issue>):<page-range>135&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.17219/acem/64983</pub-id>
</citation>
</ref>
<ref id="B203">
<label>203</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients</article-title>. <source>J Nutr</source> (<year>2015</year>) <volume>145</volume>(<issue>4</issue>):<page-range>742&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3945/jn.114.205674</pub-id>
</citation>
</ref>
<ref id="B204">
<label>204</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Couillaud</surname> <given-names>J</given-names>
</name>
<name>
<surname>Leydet</surname> <given-names>L</given-names>
</name>
<name>
<surname>Duquesne</surname> <given-names>K</given-names>
</name>
<name>
<surname>Iacazio</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>The terpene mini-path, a new promising alternative for terpenoids bio-production</article-title>. <source>Genes (Basel)</source> (<year>2021</year>) <volume>12</volume>(<issue>12</issue>):<fpage>1974</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/genes12121974</pub-id>
</citation>
</ref>
<ref id="B205">
<label>205</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petronelli</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pannitteri</surname> <given-names>G</given-names>
</name>
<name>
<surname>Testa</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Triterpenoids as new promising anticancer drugs</article-title>. <source>Anticancer Drugs</source> (<year>2009</year>) <volume>20</volume>(<issue>10</issue>):<page-range>880&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/CAD.0b013e328330fd90</pub-id>
</citation>
</ref>
<ref id="B206">
<label>206</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yousef</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Hassan</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>LY</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>ZZ</given-names>
</name>
</person-group>. <article-title>Anticancer potential and molecular targets of pristimerin: a mini- review</article-title>. <source>Curr Cancer Drug Targets</source> (<year>2017</year>) <volume>17</volume>(<issue>2</issue>):<page-range>100&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1568009616666160112105824</pub-id>
</citation>
</ref>
<ref id="B207">
<label>207</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Pristimerin induces apoptosis and autophagy <italic>via</italic> activation of ROS/ASK1/JNK pathway in human breast cancer <italic>in vitro</italic> and in vivo</article-title>. <source>Cell Death Discovery</source> (<year>2019</year>) <volume>5</volume>:<fpage>125</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41420-019-0208-0</pub-id>
</citation>
</ref>
<ref id="B208">
<label>208</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and wnt/beta-catenin signaling</article-title>. <source>Toxicol Appl Pharmacol</source> (<year>2020</year>) <volume>386</volume>:<elocation-id>114813</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.taap.2019.114813</pub-id>
</citation>
</ref>
<ref id="B209">
<label>209</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hui</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Hui</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Pristimerin inhibits LPS-triggered neurotoxicity in BV-2 microglia cells through modulating IRAK1/TRAF6/TAK1-mediated NF-kappaB and AP-1 signaling pathways in vitro</article-title>. <source>Neurotox Res</source> (<year>2018</year>) <volume>33</volume>(<issue>2</issue>):<page-range>268&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12640-017-9837-3</pub-id>
</citation>
</ref>
<ref id="B210">
<label>210</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>De-Qiong</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>DQ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>QQ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Attenuation of myocardial ischemia reperfusion injury by geniposide preconditioning in diabetic rats</article-title>. <source>Curr Res Transl Med</source> (<year>2019</year>) <volume>67</volume>(<issue>2</issue>):<fpage>35</fpage>&#x2013;<lpage>40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.retram.2019.03.002</pub-id>
</citation>
</ref>
<ref id="B211">
<label>211</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>F</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>LX</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>XH</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>YH</given-names>
</name>
</person-group>. <article-title>Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway</article-title>. <source>Acta Pharmacol Sin</source> (<year>2009</year>) <volume>30</volume>(<issue>2</issue>):<page-range>159&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/aps.2008.25</pub-id>
</citation>
</ref>
<ref id="B212">
<label>212</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koo</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Park</surname> <given-names>EH</given-names>
</name>
</person-group>. <article-title>Anti-inflammatory evaluation of gardenia extract, geniposide and genipin</article-title>. <source>J Ethnopharmacol</source> (<year>2006</year>) <volume>103</volume>(<issue>3</issue>):<fpage>496</fpage>&#x2013;<lpage>500</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2005.08.011</pub-id>
</citation>
</ref>
<ref id="B213">
<label>213</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>G</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Geniposide reduces development of streptozotocin-induced diabetic nephropathy <italic>via</italic> regulating nuclear factor-kappa b signaling pathways</article-title>. <source>Fundam Clin Pharmacol</source> (<year>2017</year>) <volume>31</volume>(<issue>1</issue>):<fpage>54</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/fcp.12231</pub-id>
</citation>
</ref>
<ref id="B214">
<label>214</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anders</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Muruve</surname> <given-names>DA</given-names>
</name>
</person-group>. <article-title>The inflammasomes in kidney disease</article-title>. <source>J Am Soc Nephrol</source> (<year>2011</year>) <volume>22</volume>(<issue>6</issue>):<page-range>1007&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1681/ASN.2010080798</pub-id>
</citation>
</ref>
<ref id="B215">
<label>215</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Callaway</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Ting</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Inflammasomes: mechanism of action, role in disease, and therapeutics</article-title>. <source>Nat Med</source> (<year>2015</year>) <volume>21</volume>(<issue>7</issue>):<page-range>677&#x2013;87</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm.3893</pub-id>
</citation>
</ref>
<ref id="B216">
<label>216</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Carroll</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Galvan-Pena</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Olden</surname> <given-names>R</given-names>
</name>
<name>
<surname>Triantafilou</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Inflammasome priming in sterile inflammatory disease</article-title>. <source>Trends Mol Med</source> (<year>2017</year>) <volume>23</volume>(<issue>2</issue>):<page-range>165&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molmed.2016.12.007</pub-id>
</citation>
</ref>
<ref id="B217">
<label>217</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Callender</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Hsue</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Artesunate: investigational drug for the treatment of severe falciparum malaria in hawai&#x2019;i</article-title>. <source>Hawaii Med J</source> (<year>2011</year>) <volume>70</volume>(<issue>4</issue>):<page-range>77&#x2013;9</page-range>.</citation>
</ref>
<ref id="B218">
<label>218</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shakeri</surname> <given-names>A</given-names>
</name>
<name>
<surname>Amini</surname> <given-names>E</given-names>
</name>
<name>
<surname>Asili</surname> <given-names>J</given-names>
</name>
<name>
<surname>Masullo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Piacente</surname> <given-names>S</given-names>
</name>
<name>
<surname>Iranshahi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Screening of several biological activities induced by different sesquiterpene lactones isolated from centaurea behen l. and rhaponticum repens (L.) hidalgo</article-title>. <source>Nat Prod Res</source> (<year>2018</year>) <volume>32</volume>(<issue>12</issue>):<page-range>1436&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14786419.2017.1344661</pub-id>
</citation>
</ref>
<ref id="B219">
<label>219</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>VL</given-names>
</name>
</person-group>. <article-title>Artesunate affords protection against aspirin-induced gastric injury by targeting oxidative stress and proinflammatory signaling</article-title>. <source>Pharmacol Rep</source> (<year>2018</year>) <volume>70</volume>(<issue>2</issue>):<page-range>390&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pharep.2017.06.003</pub-id>
</citation>
</ref>
<ref id="B220">
<label>220</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehrotra</surname> <given-names>E</given-names>
</name>
<name>
<surname>Vishwakarma</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tripathi</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Sonar</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Saraf</surname> <given-names>SK</given-names>
</name>
</person-group>. <article-title>Schizonticidal antimalarial sesquiterpene lactones from magnolia champaca (L.) baill. ex Pierre: microwave-assisted extraction, HPTLC fingerprinting and computational studies</article-title>. <source>Nat Prod Res</source> (<year>2019</year>) <volume>33</volume>(<issue>4</issue>):<page-range>568&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14786419.2017.1396595</pub-id>
</citation>
</ref>
<ref id="B221">
<label>221</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>XL</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>ZB</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>S</given-names>
</name>
<name>
<surname>An</surname> <given-names>LJ</given-names>
</name>
</person-group>. <article-title>Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by d-galactose</article-title>. <source>Pharmacol Biochem Behav</source> (<year>2007</year>) <volume>88</volume>(<issue>1</issue>):<fpage>64</fpage>&#x2013;<lpage>72</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pbb.2007.07.004</pub-id>
</citation>
</ref>
<ref id="B222">
<label>222</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>B</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Autophagy inhibition attenuates the induction of anti-inflammatory effect of catalpol in liver fibrosis</article-title>. <source>BioMed Pharmacother</source> (<year>2018</year>) <volume>103</volume>:<page-range>1262&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2018.04.156</pub-id>
</citation>
</ref>
<ref id="B223">
<label>223</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>D</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Synergistic interactions of catalpol and stachyose in STZ-HFD induced diabetic mice: synergism in regulation of blood glucose, lipids, and hepatic and renal function</article-title>. <source>Chin Herbal Medicines</source> (<year>2019</year>) <volume>11</volume>(<issue>1</issue>):<page-range>70&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.chmed.2018.05.006</pub-id>
</citation>
</ref>
<ref id="B224">
<label>224</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Chai</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Overview of pharmacological activities of andrographis paniculata and its major compound andrographolide</article-title>. <source>Crit Rev Food Sci Nutr</source> (<year>2019</year>) <volume>59</volume>(<issue>sup1</issue>):<page-range>S17&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408398.2018.1501657</pub-id>
</citation>
</ref>
<ref id="B225">
<label>225</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation <italic>via</italic> Akt/NF-kappaB pathway</article-title>. <source>Mol Cell Endocrinol</source> (<year>2016</year>) <volume>437</volume>:<page-range>268&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2016.06.029</pub-id>
</citation>
</ref>
<ref id="B226">
<label>226</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives</article-title>. <source>Theranostics</source> (<year>2021</year>) <volume>11</volume>(<issue>15</issue>):<page-range>7199&#x2013;221</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/thno.57745</pub-id>
</citation>
</ref>
<ref id="B227">
<label>227</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Triptolide: medicinal chemistry, chemical biology and clinical progress</article-title>. <source>Eur J Med Chem</source> (<year>2019</year>) <volume>176</volume>:<page-range>378&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejmech.2019.05.032</pub-id>
</citation>
</ref>
<ref id="B228">
<label>228</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>SR</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>A mechanistic overview of triptolide and celastrol, natural products from tripterygium wilfordii hook f</article-title>. <source>Front Pharmacol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>104</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2018.00104</pub-id>
</citation>
</ref>
<ref id="B229">
<label>229</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponikvar-Svet</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zeiger</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Liebman</surname> <given-names>JF</given-names>
</name>
</person-group>. <article-title>Alkaloids and selected topics in their thermochemistry</article-title>. <source>Molecules</source> (<year>2021</year>) <volume>26</volume>(<issue>21</issue>):<fpage>6715</fpage> doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26216715</pub-id>
</citation>
</ref>
<ref id="B230">
<label>230</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abookleesh</surname> <given-names>FL</given-names>
</name>
<name>
<surname>Al-Anzi</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Ullah</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Potential antiviral action of alkaloids</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>(<issue>3</issue>):<fpage>903</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27030903</pub-id>
</citation>
</ref>
<ref id="B231">
<label>231</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>FL</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>LN</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>F</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>ST</given-names>
</name>
</person-group>. <article-title>Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy</article-title>. <source>Mol Biol Rep</source> (<year>2013</year>) <volume>40</volume>(<issue>6</issue>):<page-range>3913&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11033-012-2468-0</pub-id>
</citation>
</ref>
<ref id="B232">
<label>232</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>LQ</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFbeta1-PI3K/AKT pathway</article-title>. <source>Eur J Pharmacol</source> (<year>2018</year>) <volume>824</volume>:<page-range>185&#x2013;92</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2018.01.034</pub-id>
</citation>
</ref>
<ref id="B233">
<label>233</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ni</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>HH</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>LQ</given-names>
</name>
</person-group>. <article-title>Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase b pathway in diabetic rats</article-title>. <source>J Diabetes Investig</source> (<year>2020</year>) <volume>11</volume>(<issue>2</issue>):<fpage>297</fpage>&#x2013;<lpage>306</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jdi.13119</pub-id>
</citation>
</ref>
<ref id="B234">
<label>234</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivasan</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Black pepper and its pungent principle-piperine: a review of diverse physiological effects</article-title>. <source>Crit Rev Food Sci Nutr</source> (<year>2007</year>) <volume>47</volume>(<issue>8</issue>):<page-range>735&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408390601062054</pub-id>
</citation>
</ref>
<ref id="B235">
<label>235</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haq</surname> <given-names>IU</given-names>
</name>
<name>
<surname>Imran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nadeem</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tufail</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gondal</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Mubarak</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Piperine: a review of its biological effects</article-title>. <source>Phytother Res</source> (<year>2021</year>) <volume>35</volume>(<issue>2</issue>):<fpage>680</fpage>&#x2013;<lpage>700</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ptr.6855</pub-id>
</citation>
</ref>
<ref id="B236">
<label>236</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manayi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nabavi</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Setzer</surname> <given-names>WN</given-names>
</name>
<name>
<surname>Jafari</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Piperine as a potential anti-cancer agent: a review on preclinical studies</article-title>. <source>Curr Med Chem</source> (<year>2018</year>) <volume>25</volume>(<issue>37</issue>):<page-range>4918&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/0929867324666170523120656</pub-id>
</citation>
</ref>
<ref id="B237">
<label>237</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bailly</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Cepharanthine: an update of its mode of action, pharmacological properties and medical applications</article-title>. <source>Phytomedicine</source> (<year>2019</year>) <volume>62</volume>:<elocation-id>152956</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2019.152956</pub-id>
</citation>
</ref>
<ref id="B238">
<label>238</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Du</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dou</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Pharmacological effects and clinical prospects of cepharanthine</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>(<issue>24</issue>):<fpage>8933</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27248933</pub-id>
</citation>
</ref>
<ref id="B239">
<label>239</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Lan</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Solasonine inhibits glioma growth through anti-inflammatory pathways</article-title>. <source>Am J Transl Res</source> (<year>2017</year>) <volume>9</volume>(<issue>9</issue>):<page-range>3977&#x2013;89</page-range>.</citation>
</ref>
<ref id="B240">
<label>240</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Han</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Solasonine inhibits pancreatic cancer progression with involvement of ferroptosis induction</article-title>. <source>Front Oncol</source> (<year>2022</year>) <volume>12</volume>:<elocation-id>834729</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2022.834729</pub-id>
</citation>
</ref>
<ref id="B241">
<label>241</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Solasonine relieves sevoflurane-induced neurotoxicity <italic>via</italic> activating the AMP-activated protein kinase/FoxO3a pathway</article-title>. <source>Hum Exp Toxicol</source> (<year>2022</year>) <volume>41</volume>:<elocation-id>9603271211069984</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/09603271211069984</pub-id>
</citation>
</ref>
<ref id="B242">
<label>242</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Son</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Jahng</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Progress in studies on rutaecarpine. II.&#x2013;synthesis and structure-biological activity relationships</article-title>. <source>Molecules</source> (<year>2015</year>) <volume>20</volume>(<issue>6</issue>):<page-range>10800&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules200610800</pub-id>
</citation>
</ref>
<ref id="B243">
<label>243</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byun</surname> <given-names>WS</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>ES</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>SK</given-names>
</name>
</person-group>. <article-title>Antitumor activity of rutaecarpine in human colorectal cancer cells by suppression of wnt/beta-catenin signaling</article-title>. <source>J Nat Prod</source> (<year>2022</year>) <volume>85</volume>(<issue>5</issue>):<page-range>1407&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.jnatprod.2c00224</pub-id>
</citation>
</ref>
<ref id="B244">
<label>244</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Pharmacological effects of rutaecarpine as a cardiovascular protective agent</article-title>. <source>Molecules</source> (<year>2010</year>) <volume>15</volume>(<issue>3</issue>):<page-range>1873&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules15031873</pub-id>
</citation>
</ref>
<ref id="B245">
<label>245</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname> <given-names>BZ</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>XR</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>GR</given-names>
</name>
</person-group>. <article-title>NLRP3 inflammasome in atherosclerosis: putting out the fire of inflammation</article-title>. <source>Inflammation</source> (<year>2023</year>) <volume>46</volume>(<issue>1</issue>):<fpage>35</fpage>&#x2013;<lpage>46</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-022-01725-x</pub-id>
</citation>
</ref>
<ref id="B246">
<label>246</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neelam</surname>
</name>
<name>
<surname>Khatkar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>KK</given-names>
</name>
</person-group>. <article-title>Phenylpropanoids and its derivatives: biological activities and its role in food, pharmaceutical and cosmetic industries</article-title>. <source>Crit Rev Food Sci Nutr</source> (<year>2020</year>) <volume>60</volume>(<issue>16</issue>):<page-range>2655&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408398.2019.1653822</pub-id>
</citation>
</ref>
<ref id="B247">
<label>247</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolaj</surname> <given-names>I</given-names>
</name>
<name>
<surname>Imindu Liyanage</surname> <given-names>S</given-names>
</name>
<name>
<surname>Weaver</surname> <given-names>DF</given-names>
</name>
</person-group>. <article-title>Phenylpropanoids and alzheimer&#x2019;s disease: a potential therapeutic platform</article-title>. <source>Neurochem Int</source> (<year>2018</year>) <volume>120</volume>:<fpage>99</fpage>&#x2013;<lpage>111</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.neuint.2018.08.001</pub-id>
</citation>
</ref>
<ref id="B248">
<label>248</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korkina</surname> <given-names>LG</given-names>
</name>
</person-group>. <article-title>Phenylpropanoids as naturally occurring antioxidants: from plant defense to human health</article-title>. <source>Cell Mol Biol (Noisy-le-grand)</source> (<year>2007</year>) <volume>53</volume>(<issue>1</issue>):<fpage>15</fpage>&#x2013;<lpage>25</lpage>.</citation>
</ref>
<ref id="B249">
<label>249</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>IH</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>YS</given-names>
</name>
</person-group>. <article-title>The compositions of volatiles and aroma-active compounds in dried omija fruits (Schisandra chinensis baillon) according to the cultivation areas</article-title>. <source>J Agric Food Chem</source> (<year>2011</year>) <volume>59</volume>(<issue>15</issue>):<page-range>8338&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/jf200762h</pub-id>
</citation>
</ref>
<ref id="B250">
<label>250</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yue</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Urinary and plasmatic metabolomics strategy to explore the holistic mechanism of lignans in s. chinensis in treating alzheimer&#x2019;s disease using UPLC-Q-TOF-MS</article-title>. <source>Food Funct</source> (<year>2019</year>) <volume>10</volume>(<issue>9</issue>):<page-range>5656&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c9fo00677j</pub-id>
</citation>
</ref>
<ref id="B251">
<label>251</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Schizandrin a induces the apoptosis and suppresses the proliferation, invasion and migration of gastric cancer cells by activating endoplasmic reticulum stress</article-title>. <source>Mol Med Rep</source> (<year>2021</year>) <volume>24</volume>(<issue>5</issue>):<fpage>787</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2021.12427</pub-id>
</citation>
</ref>
<ref id="B252">
<label>252</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zong</surname> <given-names>W</given-names>
</name>
<name>
<surname>Gouda</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>E</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>The antioxidant phytochemical schisandrin a promotes neural cell proliferation and differentiation after ischemic brain injury</article-title>. <source>Molecules</source> (<year>2021</year>) <volume>26</volume>(<issue>24</issue>):<fpage>7466</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26247466</pub-id>
</citation>
</ref>
<ref id="B253">
<label>253</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Use of ferulic acid in the management of diabetes mellitus and its complications</article-title>. <source>Molecules</source> (<year>2022</year>) <volume>27</volume>(<issue>18</issue>):<fpage>6010</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27186010</pub-id>
</citation>
</ref>
<ref id="B254">
<label>254</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neto-Neves</surname> <given-names>EM</given-names>
</name>
<name>
<surname>da Silva Maia Bezerra Filho</surname> <given-names>C</given-names>
</name>
<name>
<surname>Dejani</surname> <given-names>NN</given-names>
</name>
<name>
<surname>de Sousa</surname> <given-names>DP</given-names>
</name>
</person-group>. <article-title>Ferulic acid and cardiovascular health: therapeutic and preventive potential</article-title>. <source>Mini Rev Med Chem</source> (<year>2021</year>) <volume>21</volume>(<issue>13</issue>):<page-range>1625&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1389557521666210105122841</pub-id>
</citation>
</ref>
<ref id="B255">
<label>255</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Ferulic acid alleviates sciatica by inhibiting peripheral sensitization through the RhoA/p38MAPK signalling pathway</article-title>. <source>Phytomedicine</source> (<year>2022</year>) <volume>106</volume>:<elocation-id>154420</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phymed.2022.154420</pub-id>
</citation>
</ref>
<ref id="B256">
<label>256</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thapliyal</surname> <given-names>S</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>T</given-names>
</name>
<name>
<surname>Handu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bisht</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kumari</surname> <given-names>P</given-names>
</name>
<name>
<surname>Arya</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>A review on potential footprints of ferulic acid for treatment of neurological disorders</article-title>. <source>Neurochem Res</source> (<year>2021</year>) <volume>46</volume>(<issue>5</issue>):<page-range>1043&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11064-021-03257-6</pub-id>
</citation>
</ref>
<ref id="B257">
<label>257</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chowdhury</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ghosh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Das</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Sil</surname> <given-names>PC</given-names>
</name>
</person-group>. <article-title>Ferulic acid protects hyperglycemia-induced kidney damage by regulating oxidative insult, inflammation and autophagy</article-title>. <source>Front Pharmacol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>27</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2019.00027</pub-id>
</citation>
</ref>
<ref id="B258">
<label>258</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qi</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>XT</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>ZL</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Protective effect of ferulic acid on STZ-induced diabetic nephropathy in rats</article-title>. <source>Food Funct</source> (<year>2020</year>) <volume>11</volume>(<issue>4</issue>):<page-range>3706&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/c9fo02398d</pub-id>
</citation>
</ref>
<ref id="B259">
<label>259</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Naowaboot</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Hyun</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>EJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes</article-title>. <source>Exp Mol Med</source> (<year>2011</year>) <volume>43</volume>(<issue>12</issue>):<page-range>676&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3858/emm.2011.43.12.078</pub-id>
</citation>
</ref>
<ref id="B260">
<label>260</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>D</given-names>
</name>
<name>
<surname>He</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Sauchinone inhibits hypoxia-induced invasion and epithelial-mesenchymal transition in osteosarcoma cells <italic>via</italic> inactivation of the sonic hedgehog pathway</article-title>. <source>J Recept Signal Transduct Res</source> (<year>2022</year>) <volume>42</volume>(<issue>2</issue>):<page-range>173&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10799893.2021.1881556</pub-id>
</citation>
</ref>
<ref id="B261">
<label>261</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Retraction: sauchinone inhibits high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells</article-title>. <source>RSC Adv</source> (<year>2021</year>) <volume>11</volume>(<issue>9</issue>):<fpage>5243</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/d1ra90044g</pub-id>
</citation>
</ref>
<ref id="B262">
<label>262</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chae</surname> <given-names>HS</given-names>
</name>
<name>
<surname>You</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>HJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network</article-title>. <source>Sci Rep</source> (<year>2018</year>) <volume>8</volume>(<issue>1</issue>):<fpage>6737</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-018-24935-6</pub-id>
</citation>
</ref>
<ref id="B263">
<label>263</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<name>
<surname>Son</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Seo</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Song</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Kwak</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Sauchinone, a lignan from saururus chinensis, attenuates neutrophil pro-inflammatory activity and acute lung injury</article-title>. <source>Int Immunopharmacol</source> (<year>2013</year>) <volume>17</volume>(<issue>2</issue>):<page-range>471&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2013.07.011</pub-id>
</citation>
</ref>
<ref id="B264">
<label>264</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amerizadeh</surname> <given-names>F</given-names>
</name>
<name>
<surname>Rezaei</surname> <given-names>N</given-names>
</name>
<name>
<surname>Rahmani</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hassanian</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Moradi-Marjaneh</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fiuji</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Crocin synergistically enhances the antiproliferative activity of 5-flurouracil through Wnt/PI3K pathway in a mouse model of colitis-associated colorectal cancer</article-title>. <source>J Cell Biochem</source> (<year>2018</year>) <volume>119</volume>(<issue>12</issue>):<page-range>10250&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcb.27367</pub-id>
</citation>
</ref>
<ref id="B265">
<label>265</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godugu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pasari</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Khurana</surname> <given-names>A</given-names>
</name>
<name>
<surname>Anchi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Saifi</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Bansod</surname> <given-names>SP</given-names>
</name>
<etal/>
</person-group>. <article-title>Crocin, an active constituent of crocus sativus ameliorates cerulein induced pancreatic inflammation and oxidative stress</article-title>. <source>Phytother Res</source> (<year>2020</year>) <volume>34</volume>(<issue>4</issue>):<page-range>825&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ptr.6564</pub-id>
</citation>
</ref>
<ref id="B266">
<label>266</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shafahi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vaezi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Shajiee</surname> <given-names>H</given-names>
</name>
<name>
<surname>Sharafi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Khaksari</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Crocin inhibits apoptosis and astrogliosis of hippocampus neurons against methamphetamine neurotoxicity <italic>via</italic> antioxidant and anti-inflammatory mechanisms</article-title>. <source>Neurochem Res</source> (<year>2018</year>) <volume>43</volume>(<issue>12</issue>):<page-range>2252&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11064-018-2644-2</pub-id>
</citation>
</ref>
<ref id="B267">
<label>267</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HK</given-names>
</name>
</person-group>. <article-title>Crocin ameliorates atopic dermatitis symptoms by down regulation of Th2 response <italic>via</italic> blocking of NF-kappaB/STAT6 signaling pathways in mice</article-title>. <source>Nutrients</source> (<year>2018</year>) <volume>10</volume>(<issue>11</issue>):<fpage>1625</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu10111625</pub-id>
</citation>
</ref>
<ref id="B268">
<label>268</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells <italic>via</italic> miR-320/KLF5/HIF-1alpha signaling</article-title>. <source>J Cell Physiol</source> (<year>2019</year>) <volume>234</volume>(<issue>10</issue>):<page-range>17876&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcp.28418</pub-id>
</citation>
</ref>
<ref id="B269">
<label>269</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samarghandian</surname> <given-names>S</given-names>
</name>
<name>
<surname>Azimi-Nezhad</surname> <given-names>M</given-names>
</name>
<name>
<surname>Farkhondeh</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Crocin attenuate tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in streptozotocin-induced diabetic rat aorta</article-title>. <source>Cytokine</source> (<year>2016</year>) <volume>88</volume>:<page-range>20&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cyto.2016.08.002</pub-id>
</citation>
</ref>
<ref id="B270">
<label>270</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nishii</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kuwata</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nakamichi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nakanishi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sugimoto</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of pyrroloquinoline quinone and imidazole pyrroloquinoline on biological activities and neural functions</article-title>. <source>Heliyon</source> (<year>2020</year>) <volume>6</volume>(<issue>1</issue>):<elocation-id>e03240</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03240</pub-id>
</citation>
</ref>
<ref id="B271">
<label>271</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyrroloquinoline quinone decelerates rheumatoid arthritis progression by inhibiting inflammatory responses and joint destruction <italic>via</italic> modulating NF-kappaB and MAPK pathways</article-title>. <source>Inflammation</source> (<year>2016</year>) <volume>39</volume>(<issue>1</issue>):<page-range>248&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-015-0245-7</pub-id>
</citation>
</ref>
<ref id="B272">
<label>272</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyrroloquinoline quinone inhibits rotenone-induced microglia inflammation by enhancing autophagy</article-title>. <source>Molecules</source> (<year>2020</year>) <volume>25</volume>(<issue>19</issue>):<fpage>4359</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules25194359</pub-id>
</citation>
</ref>
<ref id="B273">
<label>273</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jonscher</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Chowanadisai</surname> <given-names>W</given-names>
</name>
<name>
<surname>Rucker</surname> <given-names>RB</given-names>
</name>
</person-group>. <article-title>Pyrroloquinoline-quinone is more than an antioxidant: a vitamin-like accessory factor important in health and disease prevention</article-title>. <source>Biomolecules</source> (<year>2021</year>) <volume>11</volume>(<issue>10</issue>):<fpage>1441</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom11101441</pub-id>
</citation>
</ref>
<ref id="B274">
<label>274</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van den Worm</surname> <given-names>E</given-names>
</name>
<name>
<surname>Beukelman</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Van den Berg</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Kroes</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Labadie</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Van Dijk</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils</article-title>. <source>Eur J Pharmacol</source> (<year>2001</year>) <volume>433</volume>(<issue>2-3</issue>):<page-range>225&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0014-2999(01)01516-3</pub-id>
</citation>
</ref>
<ref id="B275">
<label>275</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Touyz</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Apocynin, NADPH oxidase, and vascular cells: a complex matter</article-title>. <source>Hypertension</source> (<year>2008</year>) <volume>51</volume>(<issue>2</issue>):<page-range>172&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.103200</pub-id>
</citation>
</ref>
<ref id="B276">
<label>276</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altenhofer</surname> <given-names>S</given-names>
</name>
<name>
<surname>Radermacher</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Kleikers</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Wingler</surname> <given-names>K</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>HH</given-names>
</name>
</person-group>. <article-title>Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement</article-title>. <source>Antioxid Redox Signal</source> (<year>2015</year>) <volume>23</volume>(<issue>5</issue>):<page-range>406&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/ars.2013.5814</pub-id>
</citation>
</ref>
<ref id="B277">
<label>277</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heumuller</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wind</surname> <given-names>S</given-names>
</name>
<name>
<surname>Barbosa-Sicard</surname> <given-names>E</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>HH</given-names>
</name>
<name>
<surname>Busse</surname> <given-names>R</given-names>
</name>
<name>
<surname>Schroder</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant</article-title>. <source>Hypertension</source> (<year>2008</year>) <volume>51</volume>(<issue>2</issue>):<page-range>211&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.100214</pub-id>
</citation>
</ref>
<ref id="B278">
<label>278</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malla</surname> <given-names>R</given-names>
</name>
<name>
<surname>Marni</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chakraborty</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kamal</surname> <given-names>MA</given-names>
</name>
</person-group>. <article-title>Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer</article-title>. <source>J Pharm Anal</source> (<year>2022</year>) <volume>12</volume>(<issue>2</issue>):<page-range>221&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpha.2021.11.004</pub-id>
</citation>
</ref>
<ref id="B279">
<label>279</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname> <given-names>X</given-names>
</name>
<name>
<surname>Su</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Diallyl trisulfide, the antifungal component of garlic essential oil and the bioactivity of its nanoemulsions formed by spontaneous emulsification</article-title>. <source>Molecules</source> (<year>2021</year>) <volume>26</volume>(<issue>23</issue>):<fpage>7186</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26237186</pub-id>
</citation>
</ref>
<ref id="B280">
<label>280</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Diallyl trisulfide plays an antifibrotic role by inhibiting the expression of bcl-2 in hepatic stellate cells</article-title>. <source>J Biochem Mol Toxicol</source> (<year>2022</year>) <volume>36</volume>(<issue>8</issue>):<elocation-id>e23097</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jbt.23097</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>